BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW; International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76. [PMID: 18537184 DOI: 10.1002/hep.22322] [Cited by in Crossref: 1122] [Cited by in F6Publishing: 885] [Article Influence: 80.1] [Reference Citation Analysis]
Number Citing Articles
1 Alves SC, Fasano S, Isenberg DA. Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review. Lupus 2016;25:1509-19. [PMID: 27329649 DOI: 10.1177/0961203316655210] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
2 Stratton R, Slapak G, Mahungu T, Kinloch-de Loes S. Autoimmunity and HIV. Curr Opin Infect Dis 2009;22:49-56. [PMID: 19532080 DOI: 10.1097/QCO.0b013e3283210006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
3 Villalta D, Seaman A, Tiongson M, Warren C, Bentow C, Bizzaro N, Alessio MG, Porcelli B, Norman GL, Mahler M. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis. Clin Chem Lab Med 2020;58:1499-507. [PMID: 32286240 DOI: 10.1515/cclm-2020-0122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Buechter M, Manka P, Heinemann FM, Lindemann M, Baba HA, Schlattjan M, Canbay A, Gerken G, Kahraman A. Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. World J Gastroenterol 2018; 24(13): 1410-1418 [PMID: 29632422 DOI: 10.3748/wjg.v24.i13.1410] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
5 Strassburg CP, Manns MP. Therapy of autoimmune hepatitis. Best Pract Res Clin Gastroenterol. 2011;25:673-687. [PMID: 22117634 DOI: 10.1016/j.bpg.2011.08.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
6 Landeira G, Morise S, Fassio E, Ramonet M, Álvarez E, Caglio P, Longo C, Domínguez N. Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis. Annals of Hepatology 2012;11:100-6. [DOI: 10.1016/s1665-2681(19)31493-0] [Cited by in Crossref: 18] [Article Influence: 1.8] [Reference Citation Analysis]
7 Johanet C, Ballot E. Autoantibodies in autoimmune hepatitis: Anti-liver kidney microsome type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) antibodies. Clinics and Research in Hepatology and Gastroenterology 2013;37:216-8. [DOI: 10.1016/j.clinre.2013.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Chen Q, Gao M, Yang H, Mei L, Zhong R, Han P, Liu P, Zhao L, Wang J, Li J. Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis. BMC Gastroenterol 2022;22:23. [PMID: 35034629 DOI: 10.1186/s12876-022-02098-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mieli-vergani G, Vergani D. Sclerosing Cholangitis in Children and Adolescents. Clinics in Liver Disease 2016;20:99-111. [DOI: 10.1016/j.cld.2015.08.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
10 Franco M, Monmany J, Domingo P, Turbau M. Hepatitis autoinmune desencadenada tras el consumo de bayas de Goji. Medicina Clínica 2012;139:320-1. [DOI: 10.1016/j.medcli.2012.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
11 Diestelhorst J, Junge N, Jonigk D, Schlue J, Falk CS, Manns MP, Baumann U, Jaeckel E, Taubert R. Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis. Sci Rep 2018;8:419. [PMID: 29323192 DOI: 10.1038/s41598-017-18818-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
12 Zhang HC, Wang LS, Miller E. Hepatobiliary and Pancreatic Adverse Events. Adv Exp Med Biol 2021;1342:339-55. [PMID: 34972973 DOI: 10.1007/978-3-030-79308-1_13] [Reference Citation Analysis]
13 Balitzer D, Shafizadeh N, Peters MG, Ferrell LD, Alshak N, Kakar S. Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria. Mod Pathol. 2017;30:773-783. [PMID: 28106105 DOI: 10.1038/modpathol.2016.267] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
14 Nguyen Canh H, Harada K, Ouchi H, Sato Y, Tsuneyama K, Kage M, Nakano M, Yoshizawa K, Takahashi A, Abe M, Kang JH, Koike K, Inui A, Fujisawa T, Takaki A, Arinaga-Hino T, Torimura T, Suzuki Y, Fujiwara K, Zeniya M, Ohira H, Tanaka A, Takikawa H; Intractable Liver and Biliary Diseases Study Group of Japan. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol 2017;70:961-9. [PMID: 28428284 DOI: 10.1136/jclinpath-2016-204271] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
15 Sripongpun P, Pongpaibul A, Charatcharoenwitthaya P. Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis. BMJ Open Gastroenterol 2021;8:e000701. [PMID: 34362759 DOI: 10.1136/bmjgast-2021-000701] [Reference Citation Analysis]
16 Praharaj DL, Mallick B, Nath P, Panigrahi SC, Padhan P, Sahu N. Unusual Presentation of Systemic Lupus Erythematosus in a Young Male: A Case Report. J Clin Exp Hepatol 2021;11:264-9. [PMID: 33746453 DOI: 10.1016/j.jceh.2020.05.009] [Reference Citation Analysis]
17 Amano N, Sato S, Murata A, Tsuzura H, Tomishima K, Sato S, Matsumoto K, Shimada Y, Iijima K, Harada K, Genda T. A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis. Clin J Gastroenterol 2020;13:79-82. [PMID: 31286423 DOI: 10.1007/s12328-019-01017-2] [Reference Citation Analysis]
18 Czaja AJ. Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination. Clin Liver Dis (Hoboken) 2020;15:S72-81. [PMID: 32140216 DOI: 10.1002/cld.917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Saracco GM, Evangelista A, Fagoonee S, Ciccone G, Bugianesi E, Caviglia GP, Abate ML, Rizzetto M, Pellicano R, Smedile A. Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014. World J Gastroenterol 2016; 22(36): 8187-8193 [PMID: 27688660 DOI: 10.3748/wjg.v22.i36.8187] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
20 Efe C, Wahlin S, Ozaslan E, Purnak T, Muratori L, Quarneti C, Tatar G, Simsek H, Muratori P, Schiano TD. Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C. Scand J Gastroenterol 2013;48:504-8. [PMID: 23448312 DOI: 10.3109/00365521.2013.772231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Prasad D, Poddar U, Kanaujia V, Yachha SK, Srivastava A. Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study. Journal of Glaucoma 2019;28:929-33. [DOI: 10.1097/ijg.0000000000001352] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Vinnitskaya EV, Sandler YG, Bakulin IG, Parfenov AI, Ilchenko LY, Nikitin IG, Bueverov AO, Lopatkina TN, Ignatova ТМ, Syutkin VY, Raikhelson KL, Khomeriki SG, Gudkova RB. Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017). Ter Arkh 2018;90:12-8. [PMID: 30701766 DOI: 10.26442/terarkh201890212-18] [Reference Citation Analysis]
23 Younes R, Govaere O, Petta S, Miele L, Tiniakos D, Burt A, David E, Vecchio FM, Maggioni M, Cabibi D, Fracanzani AL, Rosso C, Blanco MJG, Armandi A, Caviglia GP, Zaki MYW, Liguori A, Francione P, Pennisi G, Grieco A, Valenti L, Anstee QM, Bugianesi E. Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease. Am J Gastroenterol 2020;115:1289-92. [PMID: 32453041 DOI: 10.14309/ajg.0000000000000676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Islam MS, Wright G, Tanner P, Lucas R. A case of anastrazole-related drug-induced autoimmune hepatitis. Clin J Gastroenterol 2014;7:414-7. [PMID: 26184021 DOI: 10.1007/s12328-014-0512-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
25 Galaski J, Weiler-Normann C, Schakat M, Zachou K, Muratori P, Lampalzer S, Haag F, Schramm C, Lenzi M, Dalekos GN, Lohse AW. Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing. J Hepatol 2021;74:312-20. [PMID: 32730794 DOI: 10.1016/j.jhep.2020.07.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gatselis NK, Vakrakou AG, Zachou K, Androutsakos T, Azariadis K, Hatzis G, Manoussakis MN, Dalekos GN. Decreased serum DNase1-activity in patients with autoimmune liver diseases. Autoimmunity 2017;50:125-32. [DOI: 10.1080/08916934.2017.1279610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, Choi BI, Wilson SR, Kudo M, Barr RG. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound Med Biol. 2018;44:2419-2440. [PMID: 30209008 DOI: 10.1016/j.ultrasmedbio.2018.07.008] [Cited by in Crossref: 152] [Cited by in F6Publishing: 110] [Article Influence: 38.0] [Reference Citation Analysis]
28 Kawaguchi T, Kohjima M, Ichikawa T, Seike M, Ide Y, Mizuta T, Honda K, Nakao K, Nakamuta M, Sata M. The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey. J Gastroenterol 2015;50:333-41. [DOI: 10.1007/s00535-014-0968-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
29 Fujiwara K, Fukuda Y, Seza K, Saito M, Yasui S, Nakano M, Yokosuka O. High level of persistent liver injury is one of clinical characteristics in treatment-naïve acute onset autoimmune hepatitis: experience in a community hospital. J Hepatobiliary Pancreat Sci 2016;23:174-80. [DOI: 10.1002/jhbp.319] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
30 Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, van Nieuwkerk KM, Drenth JP, Witteman BJ, Tuynman HA, Naber AH, Kingma PJ, van Buuren HR, van Hoek B, Vleggaar FP, van Geloven N, Beuers U, Ponsioen CY; EpiPSCPBC Study Group. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013;58:2045-55. [PMID: 23775876 DOI: 10.1002/hep.26565] [Cited by in Crossref: 383] [Cited by in F6Publishing: 314] [Article Influence: 42.6] [Reference Citation Analysis]
31 Matta B, Cabello R, Rabinovitz M, Minervini M, Malik S. Post-infantile giant cell hepatitis: A single center’s experience over 25 years. World J Hepatol 2019; 11(12): 752-760 [PMID: 31966907 DOI: 10.4254/wjh.v11.i12.752] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
32 Fujiwara K, Fukuda Y, Seza K, Saito M, Yasui S, Nakano M, Yokosuka O, Kato N. Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis. Hepatol Int 2018;12:191-9. [DOI: 10.1007/s12072-018-9848-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Efe C, Purnak T, Ozaslan E. Autoimmune hepatitis in the postpartum period. Clin Res Hepatol Gastroenterol. 2012;36:391-393. [PMID: 22481086 DOI: 10.1016/j.clinre.2012.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
34 Hübener S, Oo YH, Than NN, Hübener P, Weiler-normann C, Lohse AW, Schramm C. Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance. Clinical Gastroenterology and Hepatology 2016;14:445-53. [DOI: 10.1016/j.cgh.2015.09.037] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
35 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
36 Ferguson LA. Autoimmune hepatitis: a noninfectious killer. J Am Assoc Nurse Pract 2014;26:13-8. [PMID: 24170733 DOI: 10.1002/2327-6924.12055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Huang Y, Zhao X, Zhang ZT, Chen SS, Li SS, Shi Z, Jing J, Huang A, Guo YM, Bai ZF, Zou ZS, Xiao XH, Wang JB, Niu M. Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to Polygonum multiflorum: A Cross-Sectional Cohort Study.Front Med (Lausanne). 2020;7:592434. [PMID: 33330552 DOI: 10.3389/fmed.2020.592434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Wang P, Su H, Underhill J, Blackmore LJ, Longhi MS, Grammatikopoulos T, Okokon EV, Davies ET, Vergani D, Mieli-Vergani G, Ma Y. Autoantibody and human leukocyte antigen profiles in children with autoimmune liver disease and their first-degree relatives. J Pediatr Gastroenterol Nutr 2014;58:457-62. [PMID: 24231645 DOI: 10.1097/MPG.0000000000000245] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
39 Adar T, Mizrahi M, Pappo O, Scheiman-elazary A, Shibolet O. Adalimumab-induced Autoimmune Hepatitis. Journal of Clinical Gastroenterology 2010;44:e20-2. [DOI: 10.1097/mcg.0b013e3181a745e7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
40 Guo L, Zheng L, Hu L, Zhou H, Yu L, Liang W. Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients. Med Sci Monit 2017;23:5106-12. [PMID: 29073121 DOI: 10.12659/msm.907300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
41 McFarlane IM, Bhamra MS, Kreps A, Iqbal S, Al-Ani F, Saladini-Aponte C, Grant C, Singh S, Awwal K, Koci K, Saperstein Y, Arroyo-Mercado FM, Laskar DB, Atluri P. Gastrointestinal Manifestations of Systemic Sclerosis. Rheumatology (Sunnyvale). 2018;8. [PMID: 30057856 DOI: 10.4172/2161-1149.1000235] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
42 Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol. 2013;59:571-582. [PMID: 23603668 DOI: 10.1016/j.jhep.2013.03.015] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
43 Abe K, Takahashi A, Fujita M, Imaizumi H, Hayashi M, Okai K, Ohira H. Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease. PLoS One 2018;13:e0198757. [PMID: 29969462 DOI: 10.1371/journal.pone.0198757] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
44 Enomoto H, Nishiguchi S. Similarities and Differences in Autoimmune Hepatitis Epidemiology between East and West: Autoimmune Hepatitis in East Asia, Southeast Asia, and South Asia. Inflamm Intest Dis 2017;1:150-8. [PMID: 29922671 DOI: 10.1159/000454879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
45 Amin K, Rasool AH, Hattem A, Al-Karboly TA, Taher TE, Bystrom J. Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease. World J Gastroenterol 2017; 23(8): 1345-1352 [PMID: 28293081 DOI: 10.3748/wjg.v23.i8.1345] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
46 Tanaka T, Sugawara Y, Kokudo N. Liver transplantation and autoimmune hepatitis. Intractable Rare Dis Res 2015;4:33-8. [PMID: 25674386 DOI: 10.5582/irdr.2014.01034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
47 Ni XX, Lian M, Wu HM, Li XY, Sheng L, Bao H, Miao Q, Xiao X, Guo CJ, Li H, Ma X, Hua J. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases. World J Gastroenterol 2021; 27(1): 80-91 [PMID: 33505152 DOI: 10.3748/wjg.v27.i1.80] [Reference Citation Analysis]
48 Devarbhavi H. Response to Tinospora cordifolia (giloy)‐induced liver injury during the COVID ‐19 pandemic—Multicenter nationwide study from India. Hepatology Communications. [DOI: 10.1002/hep4.1989] [Reference Citation Analysis]
49 Deneau M, Book LS, Guthery SL, Jensen MK. Outcome after Discontinuation of Immunosuppression in Children with Autoimmune Hepatitis: A Population-Based Study. The Journal of Pediatrics 2014;164:714-719.e2. [DOI: 10.1016/j.jpeds.2013.12.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
50 Hsu TH, Tsui PH, Yu WT, Huang SF, Tai J, Wan YL, Tai DI. Cutoff Values of Acoustic Radiation Force Impulse Two-Location Measurements in Different Etiologies of Liver Fibrosis. J Med Ultrasound 2019;27:130-4. [PMID: 31867175 DOI: 10.4103/JMU.JMU_7_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Miyake Y, Yamamoto K, Matsushita H, Abe M, Takahashi A, Umemura T, Tanaka A, Nakamuta M, Nakamoto Y, Ueno Y, Saibara T, Takikawa H, Yoshizawa K, Ohira H, Zeniya M, Onji M, Tsubouchi H; Intractable Hepato-Biliary Disease Study Group of Japan. Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis: Serum anti-PD-1 antibody and type 1 AIH. Hepatol Res 2014;44:1299-307. [DOI: 10.1111/hepr.12305] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
52 Taubert R, Hupa-breier KL, Jaeckel E, Manns MP. Novel therapeutic targets in autoimmune hepatitis. Journal of Autoimmunity 2018;95:34-46. [DOI: 10.1016/j.jaut.2018.10.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
53 Tornai T, Palyu E, Vitalis Z, Tornai I, Tornai D, Antal-Szalmas P, Norman GL, Shums Z, Veres G, Dezsofi A, Par G, Par A, Orosz P, Szalay F, Lakatos PL, Papp M. Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. World J Gastroenterol 2017; 23(29): 5412-5421 [PMID: 28839442 DOI: 10.3748/wjg.v23.i29.5412] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
54 Xing X, Yan Y, Shen Y, Xue M, Wang X, Luo X, Yang L. Liver fibrosis with two-dimensional shear-wave elastography in patients with autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2020;14:631-8. [PMID: 32510248 DOI: 10.1080/17474124.2020.1779589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
55 Schaefer EA, Pratt DS. Autoimmune hepatitis: current challenges in diagnosis and management in a chronic progressive liver disease. Curr Opin Rheumatol 2012;24:84-9. [PMID: 22089102 DOI: 10.1097/BOR.0b013e32834de5d9] [Reference Citation Analysis]
56 Chen J, Liu W, Zhu W. Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients. Med Sci Monit 2019;25:6204-12. [PMID: 31422415 DOI: 10.12659/MSM.915408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
57 Schmeltzer PA, Russo MW. Clinical narrative: autoimmune hepatitis. Am J Gastroenterol 2018;113:951-8. [PMID: 29755125 DOI: 10.1038/s41395-018-0058-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
58 Bhamidimarri KR, Martin P. Are High-Dose Steroids Really Necessary in Treatment of Autoimmune Hepatitis? Clin Gastroenterol Hepatol 2019;17:1948-9. [PMID: 30885885 DOI: 10.1016/j.cgh.2019.03.018] [Reference Citation Analysis]
59 Kleiner DE. Histopathological Evaluation of Drug-Induced Liver Disease. Drug-Induced Liver Disease. Elsevier; 2013. pp. 241-63. [DOI: 10.1016/b978-0-12-387817-5.00015-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
60 Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8:530-534. [PMID: 20304098 DOI: 10.1016/j.cgh.2010.03.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
61 Hunyady P, Herrmann E, Bojunga J, Friedrich-Rust M, Pathil A, Zeuzem S, Mihm U. Diagnostic value of a liver biopsy in patients with an acute liver failure or acute liver injury. Eur J Gastroenterol Hepatol 2022;34:801-6. [PMID: 35482907 DOI: 10.1097/MEG.0000000000002382] [Reference Citation Analysis]
62 Rodrigues AT, Liu PM, Fagundes ED, Queiroz TC, de Souza Haueisen Barbosa P, Silva SL, Simões e Silva AC, Miranda DM, Ferreira AR, Alberti LR. Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome. Journal of Pediatric Gastroenterology & Nutrition 2016;63:76-81. [DOI: 10.1097/mpg.0000000000001125] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
63 Roepe IG, Vierling JM, Goss JA, Miloh T. Presentation and Outcomes of Autoimmune Hepatitis Type 1 and Type 2 in Children: A Single-center Study. J Pediatr Gastroenterol Nutr 2021;72:101-7. [PMID: 32796427 DOI: 10.1097/MPG.0000000000002892] [Reference Citation Analysis]
64 Mackay IR. A 50-year experience with autoimmune hepatitis: and where are we now? J Gastroenterol. 2011;46 Suppl 1:17-28. [PMID: 21072544 DOI: 10.1007/s00535-010-0325-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
65 Manns MP. Autoimmune hepatitis: the dilemma of rare diseases. Gastroenterology. 2011;140:1874-1876. [PMID: 21524652 DOI: 10.1053/j.gastro.2011.04.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
66 Mieli-Vergani G, Heller S, Jara P, Vergani D, Chang MH, Fujisawa T, González-Peralta RP, Kelly D, Mohan N, Shah U. Autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2009;49:158-164. [PMID: 19561543 DOI: 10.1097/mpg.0b013e3181a1c265] [Cited by in Crossref: 119] [Cited by in F6Publishing: 24] [Article Influence: 9.2] [Reference Citation Analysis]
67 Di Giorgio A, Vergani D, Mieli-vergani G. Cutting edge issues in juvenile sclerosing cholangitis. Digestive and Liver Disease 2021. [DOI: 10.1016/j.dld.2021.06.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Vierling JM. Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clin Gastroenterol Hepatol. 2015;13:2088-2108. [PMID: 26284592 DOI: 10.1016/j.cgh.2015.08.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
69 Neuhauser M, Bjornsson E, Treeprasertsuk S, Enders F, Silveira M, Talwalkar J, Lindor K. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol. 2010;105:345-353. [PMID: 19888204 DOI: 10.1038/ajg.2009.616] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
70 Baven-Pronk AM, Coenraad MJ, van Buuren HR, de Man RA, van Erpecum KJ, Lamers MM, Drenth JP, van den Berg AP, Beuers UH, den Ouden J, Koek GH, van Nieuwkerk CM, Bouma G, Brouwer JT, van Hoek B. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther. 2011;34:335-343. [PMID: 21668459 DOI: 10.1111/j.1365-2036.2011.04727.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
71 Muratori P, Carbone M, Stangos G, Perini L, Lalanne C, Ronca V, Cazzagon N, Bianchi G, Lenzi M, Floreani A, Invernizzi P, Muratori L. Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study. Dig Liver Dis 2018;50:698-702. [PMID: 29567415 DOI: 10.1016/j.dld.2018.02.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
72 Halliday N, Dyson JK, Thorburn D, Lohse AW, Heneghan MA. Review article: experimental therapies in autoimmune hepatitis. Aliment Pharmacol Ther 2020;52:1134-49. [PMID: 32794592 DOI: 10.1111/apt.16035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
73 Khedr MA, Adawy NM, Salim TA, Salem ME, Ghazy RM, Elharoun AS, Sultan MM, Ehsan NA. Kupffer Cell Hyaline Globules in Children With Autoimmune Hepatitis. Journal of Clinical and Experimental Hepatology 2022;12:20-8. [DOI: 10.1016/j.jceh.2021.04.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Terziroli Beretta-Piccoli B, Mazzucchelli L, Taiana C, Mossi G, Usai C, Vergani D, Mieli-Vergani G. A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome. J Transl Autoimmun 2020;3:100033. [PMID: 32743518 DOI: 10.1016/j.jtauto.2019.100033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 E Anastasiou O, Büchter M, A Baba H, Korth J, Canbay A, Gerken G, Kahraman A. Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience. Hepat Mon 2016;16:e40737. [PMID: 28070199 DOI: 10.5812/hepatmon.40737] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
76 Christen U, Hintermann E. Pathogen infection as a possible cause for autoimmune hepatitis. Int Rev Immunol. 2014;33:296-313. [PMID: 24911790 DOI: 10.3109/08830185.2014.921162] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
77 Kriese S, Heneghan MA. Autoimmune hepatitis. Medicine 2011;39:580-4. [DOI: 10.1016/j.mpmed.2011.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
78 van Gerven NM, de Boer YS, Zwiers A, Verwer BJ, Drenth JP, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Coenraad MJ, Kraal G, Mulder CJ, van Nieuwkerk CM, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G; Dutch Autoimmune Hepatitis Study Group. HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1. Genes Immun. 2015;16:247-252. [PMID: 25611558 DOI: 10.1038/gene.2014.82] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
79 Jones D, Manns MP, Terracciano L, Torbenson M, Vierling JM. Unmet needs and new models for future trials in autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 2018;3:363-70. [DOI: 10.1016/s2468-1253(18)30043-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
80 Tanaka A, Notohara K. Immunoglobulin G4 (IgG4)-related autoimmune hepatitis and IgG4-hepatopathy: A histopathological and clinical perspective. Hepatol Res 2021;51:850-9. [PMID: 34165225 DOI: 10.1111/hepr.13683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Wang Z, Sheng L, Yang Y, Yang F, Xiao X, Hua J, Guo C, Wei Y, Tang R, Miao Q, Zhang J, Li Y, Fang J, Qiu D, Krawitt EL, Bowlus CL, Gershwin ME, Wang Q, Ma X. The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review. Clinic Rev Allerg Immunol 2017;52:424-35. [DOI: 10.1007/s12016-016-8583-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
82 Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials. Journal of Hepatology 2010;53:191-8. [DOI: 10.1016/j.jhep.2010.01.037] [Cited by in Crossref: 103] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
83 Yousefi A, Mahmoudi E, Zare Bidoki A, Najmi Varzaneh F, Baradaran Noveiry B, Sadr M, Motamed F, Najafi M, Farahmand F, Rezaei N. IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 2016;10:659-63. [DOI: 10.1586/17474124.2016.1139449] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
84 Haque T, Sasatomi E, Hayashi PH. Drug-Induced Liver Injury: Pattern Recognition and Future Directions. Gut Liver 2016;10:27-36. [PMID: 26696029 DOI: 10.5009/gnl15114] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
85 Mendizabal M, Dip M, Demirdjian E, Lauferman L, Lopez S, Minetto J, Costaguta A, Rumbo C, Malla I, Sanchez MC, Halac E, Cervio G, Cuarterolo M, Galoppo M, Imventarza O, Bisgniano L, D’agostino D, Rubinstein F. Changing Etiologies and Prognostic Factors in Pediatric Acute Liver Failure. Liver Transpl 2019;26:268-75. [DOI: 10.1002/lt.25658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Oo YH, Hubscher SG, Adams DH. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int 2010;4:475-93. [PMID: 20827405 DOI: 10.1007/s12072-010-9183-5] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
87 Fallatah HI, Akbar HO. Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis. Libyan J Med 2010;5. [PMID: 21483590 DOI: 10.3402/ljm.v5i0.4857] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
88 Arinaga-hino T, Ide T, Miyajima I, Ogata K, Kuwahara R, Amano K, Kawaguchi T, Nakamura T, Kawaguchi T, Koga H, Yonemoto K, Torimura T; the Kurume Autoimmune Hepatitis Study Group. Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in Japan: Malignancies in patients with autoimmune hepatitis in Japan. Hepatol Res 2018;48:E222-31. [DOI: 10.1111/hepr.12973] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
89 Gatselis NK, Zachou K, Norman GL, Gabeta S, Papamichalis P, Koukoulis GK, Dalekos GN. Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity. 2013;46:471-479. [PMID: 23777462 DOI: 10.3109/08916934.2013.801461] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
90 To U, Silveira M. Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis. Clinics in Liver Disease 2018;22:603-11. [DOI: 10.1016/j.cld.2018.03.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
91 Baliss M, Kline K, Khan K, Stevenson HL. The Great Spiral Masquerader: A Case of Concurrent Secondary Syphilis and Autoimmune Hepatitis. ACG Case Rep J 2020;7:e00451. [PMID: 33062789 DOI: 10.14309/crj.0000000000000451] [Reference Citation Analysis]
92 Hassan N, Siddiqui AR, Abbas Z, Hassan SM, Soomro GB, Mubarak M, Anis S, Muzaffar R, Zafar MN. Clinical Profile and HLA Typing of Autoimmune Hepatitis From Pakistan. Hepat Mon 2013;13:e13598. [PMID: 24358040 DOI: 10.5812/hepatmon.13598] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
93 Karlsen TH, Vesterhus M, Boberg KM. Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Aliment Pharmacol Ther 2014;39:282-301. [DOI: 10.1111/apt.12581] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
94 Rigopoulou EI, Roggenbuck D, Smyk DS, Liaskos C, Mytilinaiou MG, Feist E, Conrad K, Bogdanos DP. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev. 2012;12:260-269. [PMID: 22571878 DOI: 10.1016/j.autrev.2012.04.005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
95 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol 2017; 23(33): 6030-6048 [PMID: 28970719 DOI: 10.3748/wjg.v23.i33.6030] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 45] [Article Influence: 11.8] [Reference Citation Analysis]
96 Roberts EA. Autoimmune hepatitis from the paediatric perspective. Liver International 2011;31:1424-31. [DOI: 10.1111/j.1478-3231.2011.02603.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
97 Chantran Y, Ballot E, Johanet C. Autoantibodies in autoimmune hepatitis: anti-asialoglycoprotein receptor (anti-ASGPR) antibodies. Clin Res Hepatol Gastroenterol 2012;36:510-2. [PMID: 22959101 DOI: 10.1016/j.clinre.2012.07.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Verdonk RC, Lozano MF, van den Berg AP, Gouw ASH. Bile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitis. Liver Int 2016;36:1362-9. [DOI: 10.1111/liv.13083] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
99 Zhang X, Xie QX, Zhao DM. Negative conversion of autoantibody profile in chronic hepatitis B: A case report. World J Clin Cases 2021; 9(5): 1196-1203 [PMID: 33644184 DOI: 10.12998/wjcc.v9.i5.1196] [Reference Citation Analysis]
100 Yang F, Wang Q, Bian Z, Ren LL, Jia J, Ma X. Autoimmune hepatitis: East meets west. J Gastroenterol Hepatol. 2015;30:1230-1236. [PMID: 25765710 DOI: 10.1111/jgh.12952] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
101 Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806-815. [PMID: 21544079 DOI: 10.1038/clpt.2011.58] [Cited by in Crossref: 495] [Cited by in F6Publishing: 441] [Article Influence: 45.0] [Reference Citation Analysis]
102 Tanaka A, Kono H, Leung PSC, Gershwin ME. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cell Immunol 2020;347:104021. [PMID: 31767117 DOI: 10.1016/j.cellimm.2019.104021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
103 Tsutsui A, Harada K, Tsuneyama K, Nguyen Canh H, Ando M, Nakamura S, Mizobuchi K, Baba N, Senoh T, Nagano T, Shibata H, Aoki T, Takaguchi K. Histopathological analysis of autoimmune hepatitis with "acute" presentation: Differentiation from drug-induced liver injury. Hepatol Res 2020;50:1047-61. [PMID: 32515851 DOI: 10.1111/hepr.13532] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Zhao Y, Li Y, Zhao D, Zhang H, Liu Y, Liao H, Zhang Y, Yan H. Fumarate hydratase-specific T cell response in Chinese patients with autoimmune hepatitis. Clin Res Hepatol Gastroenterol 2018;42:339-46. [PMID: 29610041 DOI: 10.1016/j.clinre.2017.12.003] [Reference Citation Analysis]
105 Prieto-González S, Cardellach F, Estruch R, Miquel R, Grau JM, Cid MC. Type 1 autoimmune hepatitis in a patient with microscopic polyangiitis: challenges in diagnosis and treatment. Med Clin (Barc) 2011;136:345-8. [PMID: 21295790 DOI: 10.1016/j.medcli.2010.10.015] [Reference Citation Analysis]
106 Christen U, Hintermann E. Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease? Front Immunol. 2018;9:163. [PMID: 29503645 DOI: 10.3389/fimmu.2018.00163] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
107 Lohse AW, Wiegard C. Diagnostic criteria for autoimmune hepatitis. Best Practice & Research Clinical Gastroenterology 2011;25:665-71. [DOI: 10.1016/j.bpg.2011.10.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
108 Li YN, Ma H, Zhou L, Zhang J, Guo LP, Li SQ, Qian YQ, Wang BM. Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients. Chin Med J (Engl) 2016;129:2434-40. [PMID: 27748335 DOI: 10.4103/0366-6999.191760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
109 Baertling F, Mayatepek E, Gerner P, Baba HA, Franzel J, Schlune A, Meissner T. Liver cirrhosis in glycogen storage disease Ib. Mol Genet Metab 2013;108:198-200. [PMID: 23357201 DOI: 10.1016/j.ymgme.2013.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
110 Mileti E, Rosenthal P, Peters MG. Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children. Clin Gastroenterol Hepatol. 2012;10:417-421.e1-2. [PMID: 22179022 DOI: 10.1016/j.cgh.2011.11.030] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
111 Czaja AJ, Bayraktar Y. Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World J Gastroenterol 2009; 15(19): 2314-2328 [PMID: 19452572 DOI: 10.3748/wjg.15.2314] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
112 Alam S, Lal BB, Sood V, Rawat D. Pediatric Acute-on-Chronic Liver Failure in a Specialized Liver Unit: Prevalence, Profile, Outcome, and Predictive Factors. J Pediatr Gastroenterol Nutr. 2016;63:400-405. [PMID: 26967824 DOI: 10.1097/mpg.0000000000001179] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
113 Purnamawati K, Ong JA, Deshpande S, Tan WK, Masurkar N, Low JK, Drum CL. The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review. Front Immunol 2018;9:1208. [PMID: 29915581 DOI: 10.3389/fimmu.2018.01208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
114 Lammert C, Zhu C, Lian Y, Raman I, Eckert G, Li QZ, Chalasani N. Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype. Hepatol Commun 2020;4:1651-63. [PMID: 33163835 DOI: 10.1002/hep4.1582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Rigopoulou EI, Zachou K, Gatselis N, Koukoulis GK, Dalekos GN. Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome. Annals of Hepatology 2014;13:127-35. [DOI: 10.1016/s1665-2681(19)30914-7] [Cited by in Crossref: 22] [Article Influence: 2.8] [Reference Citation Analysis]
116 Mancini S, Amorotti E, Vecchio S, Ponz de Leon M, Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med. 2010;5:193-200. [PMID: 20107930 DOI: 10.1007/s11739-009-0342-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]
117 Liberal R, Gaspar R, Lopes S, Macedo G. Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil. Clin Res Hepatol Gastroenterol 2021;45:101487. [PMID: 32651078 DOI: 10.1016/j.clinre.2020.06.013] [Reference Citation Analysis]
118 Tan L, Zhang Y, Peng W, Chen J, Li H, Ming F. Detection of anti-lactoferrin antibodies and anti-myeloperoxidase antibodies in autoimmune hepatitis: a retrospective study. J Immunoassay Immunochem. 2014;35:388-397. [PMID: 24547729 DOI: 10.1080/15321819.2013.879450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
119 Domerecka W, Kowalska-Kępczyńska A, Michalak A, Homa-Mlak I, Mlak R, Cichoż-Lach H, Małecka-Massalska T. Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis. Diagnostics (Basel) 2021;11:1418. [PMID: 34441353 DOI: 10.3390/diagnostics11081418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
121 Souza NP, Villar LM, Garbin AJ, Rovida TA, Garbin CA. Assessment of health-related quality of life and related factors in patients with chronic liver disease. Braz J Infect Dis 2015;19:590-5. [PMID: 26361840 DOI: 10.1016/j.bjid.2015.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
122 Goldfeld DA, Verna EC, Lefkowitch J, Swaminath A. Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn’s disease: the index case. Dig Dis Sci. 2011;56:3386-3388. [PMID: 21597977 DOI: 10.1007/s10620-011-1748-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
123 Williamson KD, Chapman RW. Primary sclerosing cholangitis: a clinical update. Br Med Bull. 2015;114:53-64. [PMID: 25981516 DOI: 10.1093/bmb/ldv019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
124 Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Yamamoto K. Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group. Dig Liver Dis. 2010;42:210-215. [PMID: 19632907 DOI: 10.1016/j.dld.2009.06.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
125 El Sankari S, Dahlqvist G, Monino L, van Pesch V. Auto-immune hepatitis in a patient with multiple sclerosis treated with alemtuzumab. Acta Neurol Belg 2018;118:331-3. [PMID: 29713905 DOI: 10.1007/s13760-018-0922-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
126 Hirschfield GM, Al-Harthi N, Heathcote EJ. Current status of therapy in autoimmune liver disease. Therap Adv Gastroenterol. 2009;2:11-28. [PMID: 21180531 DOI: 10.1177/1756283x08098966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
127 Arndtz K, Shumbayawonda E, Hodson J, Eddowes PJ, Dennis A, Thomaides-Brears H, Mouchti S, Kelly MD, Banerjee R, Neubauer S, Hirschfield GM. Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity. Hepatol Commun 2021;5:1009-20. [PMID: 34141986 DOI: 10.1002/hep4.1687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Rahim MN, Liberal R, Miquel R, Heaton ND, Heneghan MA. Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation? Liver Transpl 2019;25:946-59. [PMID: 30900368 DOI: 10.1002/lt.25451] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
129 Ducazu O, Degroote H, Geerts A, Hoorens A, Schouten J, Van Vlierberghe H, Verhelst X. Diagnostic and prognostic scoring systems for autoimmune hepatitis: a review. Acta Gastroenterol Belg 2021;84:487-95. [PMID: 34599574 DOI: 10.51821/84.3.014] [Reference Citation Analysis]
130 Chung YY, Heneghan MA. Autoimmune hepatitis in pregnancy: Pearls and pitfalls. Hepatology 2022. [PMID: 35182079 DOI: 10.1002/hep.32410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
131 Naini BV, Cortina G. A histopathologic scoring system as a tool for standardized reporting of chronic (ileo)colitis and independent risk assessment for inflammatory bowel disease. Hum Pathol. 2012;43:2187-2196. [PMID: 22703923 DOI: 10.1016/j.humpath.2012.03.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
132 De Martin E, Coilly A, Chazouillères O, Roux O, Peron JM, Houssel-Debry P, Artru F, Silvain C, Ollivier-Hourmand I, Duvoux C, Heurgue A, Barge S, Ganne-Carrié N, Pageaux GP, Besch C, Bourlière M, Fontaine H, de Ledinghen V, Dumortier J, Conti F, Radenne S, Debette-Gratien M, Goria O, Durand F, Potier P, Di Martino V, Reboux N, Ichai P, Sebagh M, Mathurin P, Agostini H, Samuel D, Duclos-Vallée JC; FILFOIE consortium – France. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score. J Hepatol 2021;74:1325-34. [PMID: 33503489 DOI: 10.1016/j.jhep.2020.12.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
133 Wei Y, Li Y, Yan L, Sun C, Miao Q, Wang Q, Xiao X, Lian M, Li B, Chen Y, Zhang J, Li Y, Huang B, Li Y, Cao Q, Fan Z, Chen X, Fang JY, Gershwin ME, Tang R, Ma X. Alterations of gut microbiome in autoimmune hepatitis. Gut 2020;69:569-77. [PMID: 31201284 DOI: 10.1136/gutjnl-2018-317836] [Cited by in Crossref: 109] [Cited by in F6Publishing: 98] [Article Influence: 54.5] [Reference Citation Analysis]
134 Xue M, Shen Y, Fan X, Shen M, Yang L. Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis.Can J Gastroenterol Hepatol. 2021;2021:6692511. [PMID: 33489994 DOI: 10.1155/2021/6692511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Mogahed E, El-Karaksy H, Zaki H, Abdullatif H. Autoimmune hepatitis in Egyptian children: A single center experience. Int J Immunopathol Pharmacol 2022;36:20587384211073265. [PMID: 35231187 DOI: 10.1177/20587384211073265] [Reference Citation Analysis]
136 Makol A, Watt KD, Chowdhary VR. Autoimmune hepatitis: a review of current diagnosis and treatment. Hepat Res Treat. 2011;2011:390916. [PMID: 21760995 DOI: 10.1155/2011/390916] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
137 Mieli-vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, Fischler B, Gupte G, Hierro L, Indolfi G, Jahnel J, Smets F, Verkade HJ, Hadžić N. Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. Journal of Pediatric Gastroenterology & Nutrition 2018;66:345-60. [DOI: 10.1097/mpg.0000000000001801] [Cited by in Crossref: 100] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
138 Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, Torimura T, Yoshizawa K, Takaki A, Kang JH, Suzuki Y, Nakamoto N, Inui A, Tanaka A, Takikawa H. Differences in autoimmune hepatitis based on inflammation localization. Med Mol Morphol 2021;54:8-13. [PMID: 32410010 DOI: 10.1007/s00795-020-00255-5] [Reference Citation Analysis]
139 Lian M, Zhang J, Zhao L, Chen X, Peng Y, Wang Q, Chen S, Ma X. Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells. Front Immunol 2019;10:2577. [PMID: 31787974 DOI: 10.3389/fimmu.2019.02577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
140 Takai S, Inoue J, Kogure T, Kakazu E, Ninomiya M, Iwata T, Umetsu T, Nakamura T, Sano A, Shimosegawa T. Acute-onset Autoimmune Hepatitis in a Young Woman with Type 1 Diabetes Mellitus. Intern Med 2018;57:1591-6. [PMID: 29321432 DOI: 10.2169/internalmedicine.9728-17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Mieli-Vergani G, Vergani D. Autoimmune hepatitis in childhood. Clin Liver Dis (Hoboken) 2014;3:6-8. [PMID: 30992879 DOI: 10.1002/cld.296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
142 Arahata M, Tajiri K, Nomoto K, Tsuneyama K, Minami S, Shimizu Y. A novel type of selective immunoglobulin m deficiency in a patient with autoimmune liver cirrhosis with recurrent hepatocellular carcinoma: a case report and review of the literature. Int Arch Allergy Immunol 2013;161:91-6. [PMID: 23257944 DOI: 10.1159/000343583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
143 Bessone F, Lucena MI, Roma MG, Stephens C, Medina-Cáliz I, Frider B, Tsariktsian G, Hernández N, Bruguera M, Gualano G, Fassio E, Montero J, Reggiardo MV, Ferretti S, Colombato L, Tanno F, Ferrer J, Zeno L, Tanno H, Andrade RJ. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases. Liver Int 2016;36:302-10. [PMID: 26104271 DOI: 10.1111/liv.12899] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
144 Beal EW, Black SM, Michaels A. Autoimmune Hepatitis in the Liver Transplant Graft. Clin Liver Dis 2017;21:381-401. [PMID: 28364820 DOI: 10.1016/j.cld.2016.12.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
145 Takahashi H, Zeniya M. Acute presentation of autoimmune hepatitis: Does it exist? A published work review. Hepatol Res. 2011;41:498-504. [PMID: 21595804 DOI: 10.1111/j.1872-034x.2011.00808.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
146 Kumar BGV, Sethy PC, Gupta R. A rare etiology of persistent jaundice in type 1 autoimmune hepatitis. Arch Clin Cases 2021;8:37-41. [PMID: 34984223 DOI: 10.22551/2021.32.0803.10183] [Reference Citation Analysis]
147 Comerford M, Fogel R, Bailey JR, Chilukuri P, Chalasani N, Lammert CS. Leveraging Social Networking Sites for an Autoimmune Hepatitis Genetic Repository: Pilot Study to Evaluate Feasibility. J Med Internet Res 2018;20:e14. [PMID: 29348111 DOI: 10.2196/jmir.7683] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
148 Biewenga M, Inderson A, Tushuizen ME, Crobach ASLP, van Hoek B. Early Predictors of Short-Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis. Liver Transpl 2020;26:1573-81. [PMID: 32997870 DOI: 10.1002/lt.25906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
149 Villa M, Black S, Groth N, Rothman KJ, Apolone G, Weiss NS, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Crucitti A, Della Cioppa G, Scarpini E, Mavilio D, Mannino S. Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy. Am J Epidemiol 2013;178:1139-45. [PMID: 23863759 DOI: 10.1093/aje/kwt078] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
150 Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. J Immunol Res 2019;2019:9437043. [PMID: 31886312 DOI: 10.1155/2019/9437043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
151 Costaguta A, González A, Pochettino S, Trotta L, Vicentín R, Wagener M. Incidence and Clinical Features of Autoimmune Hepatitis in the Province of Santa Fe (Argentina). J Pediatr Gastroenterol Nutr 2018;67:e107-10. [PMID: 30095578 DOI: 10.1097/MPG.0000000000002122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
152 Krawitt EL. Discrimination of autoimmune hepatitis: autoantibody typing and beyond. J Gastroenterol 2011;46 Suppl 1:39-41. [PMID: 20862497 DOI: 10.1007/s00535-010-0324-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
153 Sebode M, Schulz L, Lohse AW. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. Int J Mol Sci 2017;18:E1954. [PMID: 28895915 DOI: 10.3390/ijms18091954] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
154 Ju HY, Jang JY, Jeong SW, Woo SA, Kong MG, Jang HY, Lee SH, Kim SG, Cha SW, Kim YS. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis. Clin Mol Hepatol. 2012;18:213-218. [PMID: 22893872 DOI: 10.3350/cmh.2012.18.2.213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
155 Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, Stedman CA. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol. 2010;25:1681-1686. [PMID: 20880179 DOI: 10.1111/j.1440-1746.2010.06384.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 100] [Article Influence: 10.0] [Reference Citation Analysis]
156 Guindi M. Histology of autoimmune hepatitis and its variants. Clin Liver Dis. 2010;14:577-590. [PMID: 21055683 DOI: 10.1016/j.cld.2010.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
157 Yamamoto K, Miyake Y, Ohira H, Suzuki Y, Zeniya M, Onji M, Tsubouchi H; Intractable Liver and Biliary Diseases Study Group of Japan. Prognosis of autoimmune hepatitis showing acute presentation: AIH with acute presentation. Hepatol Res 2013;43:630-8. [DOI: 10.1111/j.1872-034x.2012.01109.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
158 Yokokawa J, Saito H, Kanno Y, Honma F, Monoe K, Sakamoto N, Abe K, Takahashi A, Yokokawa H, Ohira H. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. J Gastroenterol Hepatol. 2010;25:376-382. [PMID: 19817953 DOI: 10.1111/j.1440-1746.2009.06018.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
159 Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010;51:2040-8. [PMID: 20512992 DOI: 10.1002/hep.23588] [Cited by in Crossref: 298] [Cited by in F6Publishing: 250] [Article Influence: 24.8] [Reference Citation Analysis]
160 Bailloud R, Bertin D, Roquelaure B, Roman C, Ballot E, Johanet C, Desplat-jégo S. Anti-mitochondrial-2 antibodies (anti-PDC-E2): A marker for autoimmune hepatitis of children? Clinics and Research in Hepatology and Gastroenterology 2012;36:e57-9. [DOI: 10.1016/j.clinre.2012.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
161 Zhang H, Liu M, Zhong W, Zheng Y, Li Y, Guo L, Zhang Y, Ran Y, Zhao J, Zhou L, Wang B. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis. Front Immunol 2021;12:624360. [PMID: 33841405 DOI: 10.3389/fimmu.2021.624360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Zhang W, De D, Mohammed KA, Munigala S, Chen G, Lai JP, Bacon BR. New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome. Hepatol Commun 2018;2:245-53. [PMID: 29507900 DOI: 10.1002/hep4.1148] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
163 Abe K, Takahashi A, Fujita M, Hayashi M, Okai K, Nozawa Y, Ohira H. Interleukin-33/ST2-Mediated Inflammation Plays a Critical Role in the Pathogenesis and Severity of Type I Autoimmune Hepatitis. Hepatol Commun 2019;3:670-84. [PMID: 31061955 DOI: 10.1002/hep4.1326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
164 Wang QX, Yan L, Ma X. Autoimmune Hepatitis in the Asia-Pacific Area. J Clin Transl Hepatol 2018;6:48-56. [PMID: 29577032 DOI: 10.14218/JCTH.2017.00032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
165 Anastasiou OE, Dogan-Cavus B, Kucukoglu O, Baba H, Kahraman A, Gerken G, Schramm C, Canbay A. Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure. Digestion 2018;98:104-11. [PMID: 29698940 DOI: 10.1159/000487940] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
166 Schulz L, Sebode M, Weidemann SA, Lohse AW. Variant syndromes of primary biliary cholangitis. Best Practice & Research Clinical Gastroenterology 2018;34-35:55-61. [DOI: 10.1016/j.bpg.2018.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
167 Webster CRL, Center SA, Cullen JM, Penninck DG, Richter KP, Twedt DC, Watson PJ. ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. J Vet Intern Med 2019;33:1173-200. [PMID: 30844094 DOI: 10.1111/jvim.15467] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
168 Shroff H, Fix OK. Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: Real or Imagined? Dig Dis Sci 2022. [PMID: 35534745 DOI: 10.1007/s10620-022-07509-5] [Reference Citation Analysis]
169 Sernoskie SC, Jee A, Uetrecht JP. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions. Pharmacol Rev 2021;73:861-96. [PMID: 34016669 DOI: 10.1124/pharmrev.120.000090] [Reference Citation Analysis]
170 Mazzara S, Sinisi A, Cardaci A, Rossi RL, Muratori L, Abrignani S, Bombaci M. Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis. PLoS One 2015;10:e0137927. [PMID: 26375394 DOI: 10.1371/journal.pone.0137927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
171 Mayo MJ. Cholestatic Liver Disease Overlap Syndromes. Clinics in Liver Disease 2013;17:243-53. [DOI: 10.1016/j.cld.2012.12.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
172 Cohen J, Hariton E, Kothari D, Pihan GA, Robson SC. Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis. J Gastrointest Oncol 2013;4:131-6. [PMID: 23730508 DOI: 10.3978/j.issn.2078-6891.2013.017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
173 Soares A, Cunha R, Rodrigues F, Ribeiro H. Smooth muscle autoantibodies with F-actin specificity. Autoimmun Rev 2009;8:713-6. [PMID: 19232552 DOI: 10.1016/j.autrev.2009.02.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
174 Chapman MH, Thorburn D, Hirschfield GM, Webster GGJ, Rushbrook SM, Alexander G, Collier J, Dyson JK, Jones DE, Patanwala I, Thain C, Walmsley M, Pereira SP. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut 2019;68:1356-78. [PMID: 31154395 DOI: 10.1136/gutjnl-2018-317993] [Cited by in Crossref: 86] [Cited by in F6Publishing: 62] [Article Influence: 28.7] [Reference Citation Analysis]
175 Macaluso FS, Sapienza C, Ventimiglia M, Renna S, Cottone M, Orlando A. Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohort. Scand J Gastroenterol 2019;54:1102-6. [PMID: 31491360 DOI: 10.1080/00365521.2019.1663260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
176 Bernal-Macías S, Reyes-Beltrán B, Molano-González N, Augusto Vega D, Bichernall C, Díaz LA, Rojas-Villarraga A, Anaya JM. Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med 2015;2:e000122. [PMID: 26688741 DOI: 10.1136/lupus-2015-000122] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
177 Zachou K, Weiler‐normann C, Muratori L, Muratori P, Lohse AW, Dalekos GN. Permanent immunosuppression in SLA/LP‐positive autoimmune hepatitis is required although overall response and survival are similar. Liver Int 2020;40:368-76. [DOI: 10.1111/liv.14280] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
178 Li KK, Neuberger J. Recurrent nonviral liver disease following liver transplantation. Expert Rev Gastroenterol Hepatol. 2009;3:257-268. [PMID: 19485808 DOI: 10.1586/egh.09.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
179 Liberal R, Grant CR, Mieli-vergani G, Vergani D. Autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2013;41:126-39. [DOI: 10.1016/j.jaut.2012.11.002] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 13.9] [Reference Citation Analysis]
180 Lapierre P, Béland K, Martin C, Alvarez F Jr, Alvarez F. Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis. Hepatology 2010;51:1789-98. [PMID: 20232291 DOI: 10.1002/hep.23536] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
181 Liu Y, Liu H, Zhu J, Bian Z. Interleukin-34 drives macrophage polarization to the M2 phenotype in autoimmune hepatitis. Pathology - Research and Practice 2019;215:152493. [DOI: 10.1016/j.prp.2019.152493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Agrawal S, Duseja A, Gupta T, Dhiman RK, Chawla Y. Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure. J Gastroenterol Hepatol. 2015;30:575-581. [PMID: 25251968 DOI: 10.1111/jgh.12778] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
183 Oeda S, Mizuta T, Isoda H, Kuwashiro T, Oza N, Iwane S, Takahashi H, Kawaguchi Y, Eguchi Y, Toda S. Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis. Clin J Gastroenterol. 2012;5:141-145. [PMID: 22593772 DOI: 10.1007/s12328-012-0295-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
184 Keppeke GD, Nunes E, Ferraz ML, Silva EA, Granato C, Chan EK, Andrade LE. Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods/rings following HCV therapy with ribavirin and interferon-α. PLoS One. 2012;7:e45392. [PMID: 23028980 DOI: 10.1371/journal.pone.0045392] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
185 Yamada M, Shibata H, Masugi Y, Ishi T, Kameyama K, Ebinuma H, Hasegawa T. Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report. Intern Med. 2017;56:2139-2143. [PMID: 28781316 DOI: 10.2169/internalmedicine.8417-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
186 Radzimski C, Probst C, Teegen B, Rentzsch K, Blöcker IM, Dähnrich C, Schlumberger W, Stöcker W, Bogdanos DP, Komorowski L. Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis. Clin Dev Immunol 2013;2013:572815. [PMID: 23401700 DOI: 10.1155/2013/572815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
187 Niţă AF, Păcurar D. Adequacy of scoring systems in diagnosing paediatric autoimmune hepatitis: retrospective study using a control group children with Hepatitis B infection. Acta Paediatr 2019;108:1717-24. [PMID: 30703247 DOI: 10.1111/apa.14730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
188 Czaja AJ. The overlap syndromes of autoimmune hepatitis. Dig Dis Sci. 2013;58:326-343. [PMID: 22918690 DOI: 10.1007/s10620-012-2367-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 25] [Article Influence: 0.4] [Reference Citation Analysis]
189 Kuzu UB, Öztaş E, Turhan N, Saygili F, Suna N, Yildiz H, Kaplan M, Akpinar MY, Akdoğan M, Kaçar S, Kiliç ZM, Köksal AŞ, Ödemiş B, Kayaçetin E. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis. Hepatol Res 2016;46:277-91. [PMID: 25926402 DOI: 10.1111/hepr.12530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
190 Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, Manns MP, Norman GL, Lee WM; Acute Liver Failure Study Group. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011;53:517-26. [PMID: 21274872 DOI: 10.1002/hep.24080] [Cited by in Crossref: 193] [Cited by in F6Publishing: 147] [Article Influence: 17.5] [Reference Citation Analysis]
191 Tanaka A. Autoimmune Hepatitis: 2019 Update. Gut Liver 2020;14:430-8. [PMID: 32301319 DOI: 10.5009/gnl19261] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
192 Dalekos GN, Azariadis K, Lygoura V, Arvaniti P, Gampeta S, Gatselis NK. Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome. Liver Int 2021;41:1592-9. [PMID: 33896089 DOI: 10.1111/liv.14900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
193 Zeman MV, Hirschfield GM. Autoantibodies and liver disease: uses and abuses. Can J Gastroenterol 2010;24:225-31. [PMID: 20431809 DOI: 10.1155/2010/431913] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
194 Taneja S, Kumar P, Mitra S, Duseja A, Minz R, Das A, Dhiman RK, Chawla Y. Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature. J Clin Exp Hepatol 2018;8:98-103. [PMID: 29743801 DOI: 10.1016/j.jceh.2017.08.005] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
195 Dai M, Zhao P, Bei ML, Zhang GQ. Autoimmune hepatitis complicated by Sjogren syndrome and Hashimoto thyroiditis with leukopenia: A report of one case. Shijie Huaren Xiaohua Zazhi 2012; 20(17): 1585-1587 [DOI: 10.11569/wcjd.v20.i17.1585] [Reference Citation Analysis]
196 Rodrigo-nicolás B, Velasco-pastor M, Molés-poveda P, González-lópez O. Debut de hepatitis crónica autoinmune como prúrigo nodular. Gastroenterología y Hepatología 2014;37:462-4. [DOI: 10.1016/j.gastrohep.2014.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
197 Liberal R, Selmi C, Gershwin ME. Diego and Giorgina Vergani: The two hearts of translational autoimmunity. Journal of Autoimmunity 2016;66:1-6. [DOI: 10.1016/j.jaut.2015.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
198 Polychronopoulou E, Lygoura V, Gatselis NK, Dalekos GN. Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis. BMJ Case Rep. 2017;2017. [PMID: 28951510 DOI: 10.1136/bcr-2017-220824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
199 Zachou K, Gatselis NK, Arvaniti P, Gabeta S, Rigopoulou EI, Koukoulis GK, Dalekos GN. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis. Aliment Pharmacol Ther. 2016;43:1035-1047. [PMID: 26991238 DOI: 10.1111/apt.13584] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 10.3] [Reference Citation Analysis]
200 Abdel-Razik A, Mousa N, Zakaria S, Elhelaly R, Elzehery R, Zalata K, Awad M, Eldeeb AA, Abdelsalam M. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume. Eur J Gastroenterol Hepatol 2017;29:1373-9. [PMID: 29035910 DOI: 10.1097/MEG.0000000000000982] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
201 Zhao SX, Zhang QS, Kong L, Zhang YG, Wang RQ, Nan YM, Kong LB. Dichlorvos induced autoimmune hepatitis: a case report and review of literature. Hepat Mon 2015;15:e25469. [PMID: 26034503 DOI: 10.5812/hepatmon.25469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
202 Fujiwara K, Yasui S, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis: Diagnostic criteria for acute-onset AIH. Liver International 2011;31:1013-20. [DOI: 10.1111/j.1478-3231.2011.02524.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
203 Abe K, Kanno Y, Okai K, Katsushima F, Monoe K, Saito H, Takahashi A, Yokokawa J, Ohira H. Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis. World J Hepatol 2012; 4(9): 262-267 [PMID: 23060971 DOI: 10.4254/wjh.v4.i9.262] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
204 Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, Möller S, Lohse AW. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol. 2013;58:529-534. [PMID: 23178709 DOI: 10.1016/j.jhep.2012.11.010] [Cited by in Crossref: 135] [Cited by in F6Publishing: 112] [Article Influence: 13.5] [Reference Citation Analysis]
205 Wang Q, Selmi C, Zhou X, Qiu D, Li Z, Miao Q, Chen X, Wang J, Krawitt EL, Gershwin ME, Han Y, Ma X. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. Journal of Autoimmunity 2013;41:140-5. [DOI: 10.1016/j.jaut.2012.10.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
206 Di Giorgio A, D'Adda A, Marseglia A, Sonzogni A, Licini L, Nicastro E, D'Antiga L. Biliary features in liver histology of children with autoimmune liver disease. Hepatol Int 2019;13:510-8. [PMID: 31069759 DOI: 10.1007/s12072-019-09948-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
207 Liu K, Wang R, Kariyawasam V, Wells M, Strasser SI, McCaughan G, Corte C, Leong RW. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort. Liver Int. 2017;37:442-448. [PMID: 27891750 DOI: 10.1111/liv.13328] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
208 Lal D, Thakur M, Bihari C. Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis. J Clin Exp Hepatol 2020;10:574-80. [PMID: 33311894 DOI: 10.1016/j.jceh.2020.04.014] [Reference Citation Analysis]
209 de Boer YS, Liberal R, Vergani D, Mieli-Vergani G. Real-world management of juvenile autoimmune liver disease. United European Gastroenterol J 2018;6:1032-8. [PMID: 30228891 DOI: 10.1177/2050640618768922] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
210 Lian M, Li B, Xiao X, Yang Y, Jiang P, Yan L, Sun C, Zhang J, Wei Y, Li Y, Chen W, Jiang X, Miao Q, Chen X, Qiu D, Sheng L, Hua J, Tang R, Wang Q, Eric Gershwin M, Ma X. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone. Autoimmun Rev. 2017;16:875-882. [PMID: 28564616 DOI: 10.1016/j.autrev.2017.05.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
211 Christen U. Animal models of autoimmune hepatitis. Biochim Biophys Acta Mol Basis Dis 2019;1865:970-81. [PMID: 29857050 DOI: 10.1016/j.bbadis.2018.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
212 Rocha HC, Vilela EG. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases. Gastroenterol Hepatol 2021:S0210-5705(21)00153-9. [PMID: 34023469 DOI: 10.1016/j.gastrohep.2021.03.011] [Reference Citation Analysis]
213 Mieli-vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol 2011;8:320-9. [DOI: 10.1038/nrgastro.2011.69] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 7.5] [Reference Citation Analysis]
214 Chen Y, Hua X, Huang B, Karsten S, You Z, Li B, Li Y, Li Y, Liang J, Zhang J, Wei Y, Chen R, Lyu Z, Xiao X, Lian M, Wei J, Fang J, Miao Q, Wang Q, Berglung UW, Tang R, Helleday T, Ma X. MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells. Hepatol Commun 2021. [PMID: 34894107 DOI: 10.1002/hep4.1862] [Reference Citation Analysis]
215 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51:237-267. [PMID: 19501929 DOI: 10.1016/j.jhep.2009.04.009] [Cited by in Crossref: 1087] [Cited by in F6Publishing: 941] [Article Influence: 83.6] [Reference Citation Analysis]
216 Dyson JK, De Martin E, Dalekos GN, Drenth JP, Herkel J, Hubscher SG, Kelly D, Lenzi M, Milkiewicz P, Oo YH, Heneghan MA, Lohse AW; the IAIHG Consortium. Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther 2019;49:528-36. [DOI: 10.1111/apt.15111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
217 Fourman LT, Robert Meyer B. Autoimmune hepatitis in association with ramelteon. J Clin Gastroenterol. 2013;47:651-654. [PMID: 23632362 DOI: 10.1097/MCG.0b013e31829174f0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
218 . EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015;63:971-1004. [DOI: 10.1016/j.jhep.2015.06.030] [Cited by in Crossref: 489] [Cited by in F6Publishing: 395] [Article Influence: 69.9] [Reference Citation Analysis]
219 van Gerven NM, de Boer YS, Mulder CJ, van Nieuwkerk CM, Bouma G. Auto immune hepatitis. World J Gastroenterol 2016; 22(19): 4651-4661 [PMID: 27217697 DOI: 10.3748/wjg.v22.i19.4651] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
220 Lin YN, Chou JW, Cheng KS, Peng CY, Jeng LB, Chiang IP. Treatment of Fulminant Autoimmune Hepatitis: Corticosteroid Therapy or Liver Transplantation? A Case Report and Literature Review. Gastroenterology Res 2011;4:231-5. [PMID: 27957021 DOI: 10.4021/gr323w] [Reference Citation Analysis]
221 Christen U, Hintermann E. Pathogens and autoimmune hepatitis. Clin Exp Immunol. 2019;195:35-51. [PMID: 30113082 DOI: 10.1111/cei.13203] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
222 Kurowski J, Melin-Aldana H, Bass L, Alonso EM, Ekong UD. Sirolimus as rescue therapy in pediatric autoimmune hepatitis. J Pediatr Gastroenterol Nutr. 2014;58:e4-e6. [PMID: 23539046 DOI: 10.1097/mpg.0b013e318291feaa] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
223 Muratori P, Lenzi M, Migliori M, Muratori L. Antimitochondrial antibodies positive autoimmune hepatitis with acute onset. Scand J Gastroenterol 2017;52:920-1. [PMID: 28388847 DOI: 10.1080/00365521.2017.1311937] [Reference Citation Analysis]
224 Czaja AJ. Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Can J Gastroenterol. 2013;27:417-423. [PMID: 23862175 DOI: 10.1155/2013/198070] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
225 Bossuyt X, De Langhe E, Borghi MO, Meroni PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol 2020;16:715-26. [PMID: 33154583 DOI: 10.1038/s41584-020-00522-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
226 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145-172. [PMID: 28427765 DOI: 10.1016/j.jhep.2017.03.022] [Cited by in Crossref: 409] [Cited by in F6Publishing: 326] [Article Influence: 81.8] [Reference Citation Analysis]
227 Franco DL, Kale S, Lam-Himlin DM, Harrison ME. Black Cohosh Hepatotoxicity with Autoimmune Hepatitis Presentation. Case Rep Gastroenterol 2017;11:23-8. [PMID: 28203134 DOI: 10.1159/000452735] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
228 Teufel A, Galle PR, Kanzler S. Update on autoimmune hepatitis. World J Gastroenterol 2009; 15(9): 1035-1041 [PMID: 19266594 DOI: 10.3748/wjg.15.1035] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
229 Mieli-Vergani G, Vergani D. Autoimmune liver disease in Asian children. Hepatol Int 2015;9:157-60. [PMID: 25788190 DOI: 10.1007/s12072-014-9602-0] [Reference Citation Analysis]
230 Llovet LP, Gratacós-Ginés J, Ortiz O, Rodriguez-Tajes S, Lens S, Reverter E, Ruiz-Ortiz E, Costa J, Viñas O, Forns X, Parés A, Londoño MC. Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodies. Liver Int 2020;40:558-64. [PMID: 31863722 DOI: 10.1111/liv.14332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
231 Martínez Casas OY, Díaz Ramírez GS, Marín Zuluaga JI, Santos Ó, Muñoz Maya O, Donado Gómez JH, Restrepo Gutiérrez JC. Síndrome de superposición: hepatitis autoinmune y colangitis biliar primaria. Resultados a largo plazo de una cohorte retrospectiva en un hospital universitario. Gastroenterología y Hepatología 2018;41:544-52. [DOI: 10.1016/j.gastrohep.2018.05.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
232 Kerkar N, Vergani D. De novo autoimmune hepatitis –is this different in adults compared to children? Journal of Autoimmunity 2018;95:26-33. [DOI: 10.1016/j.jaut.2018.10.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
233 Di Giorgio A, Hadzic N, Dhawan A, Deheragoda M, Heneghan MA, Vergani D, Mieli-vergani G, Samyn M. Seamless Management of Juvenile Autoimmune Liver Disease: Long-Term Medical and Social Outcome. The Journal of Pediatrics 2020;218:121-129.e3. [DOI: 10.1016/j.jpeds.2019.11.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
234 Liberal R, Vergani D, Mieli-vergani G. Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation. Liver Transpl 2016;22:1275-83. [DOI: 10.1002/lt.24490] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
235 Liu Y, Hao H, Hou T. Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook. Open Life Sciences 2022;17:91-101. [DOI: 10.1515/biol-2022-0013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Liberal R, Mieli-Vergani G, Vergani D. Contemporary issues and future directions in autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2016;10:1163-74. [PMID: 27215278 DOI: 10.1080/17474124.2016.1193004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
237 Hadley TA, Palle SK, Venkateswaran S, Abramowsky C, Gillespie S, Hall L, Kolachala VL, Gupta NA. A two decade long study of disease progression of de novo and recurrent autoimmune hepatitis in the pediatric population. Pediatr Transplant 2021;25:e13978. [PMID: 33522659 DOI: 10.1111/petr.13978] [Reference Citation Analysis]
238 Defilippis EM, Kumar S. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease. Dig Dis Sci 2015;60:2873-80. [DOI: 10.1007/s10620-015-3699-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
239 Tunio NA, Mansoor E, Sheriff MZ, Cooper GS, Sclair SN, Cohen SM. Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019: A Population-based National Study. J Clin Gastroenterol 2021;55:903-10. [PMID: 33074948 DOI: 10.1097/MCG.0000000000001449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
240 Ghanadan A, Saghazadeh A, Jahanzad I, Rezaei N. Clinical aspects of indirect immunofluorescence for autoimmune diseases. Expert Rev Clin Immunol 2015;11:597-616. [PMID: 25786676 DOI: 10.1586/1744666X.2015.1027152] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
241 Cascino MD, McNabb B, Gardner DG, Woeber KA, Fox AN, Wang B, Fix OK. Acute liver failure with thyrotoxicosis treated with liver transplantation. Endocr Pract 2013;19:e57-60. [PMID: 23337142 DOI: 10.4158/EP12219.CR] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
242 Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
243 Wang H, Yan W, Feng Z, Gao Y, Zhang L, Feng X, Tian D. Plasma proteomic analysis of autoimmune hepatitis in an improved AIH mouse model. J Transl Med 2020;18:3. [PMID: 31906950 DOI: 10.1186/s12967-019-02180-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Seife Hassen S, Ata F, Bint I Bilal A, Salih Ali M, Petkar M, Awad Elzouki AY, Zahid M. Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report. Clin Case Rep 2020;8:3421-6. [PMID: 33363945 DOI: 10.1002/ccr3.3421] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
245 Zhong C, Xi Z, Xia Q. Clinical analysis of liver transplantation in autoimmune liver diseases. Hepatobiliary & Pancreatic Diseases International 2018;17:27-31. [DOI: 10.1016/j.hbpd.2018.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
246 Mieli-Vergani G, Vergani D. The Riddle of Juvenile Sclerosing Cholangitis. Hepatology 2017;66:315-7. [PMID: 28407274 DOI: 10.1002/hep.29208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
247 Rigopoulou EI, Gyftaki S, Arvaniti P, Tsimourtou V, Koukoulis GK, Hadjigeorgiou G, Dalekos GN. Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment. Clin Res Hepatol Gastroenterol 2019;43:e25-32. [PMID: 30594597 DOI: 10.1016/j.clinre.2018.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
248 Somroo GB, Rai AA, Luck NH, Abbas Z. Clinical presentation of autoimmune hepatitis in Pakistani children. Pan Afr Med J 2018;30:117. [PMID: 30364457 DOI: 10.11604/pamj.2018.30.117.12692] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
249 de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH; Drug-Induced Liver Injury Network. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol 2017;15:103-112.e2. [PMID: 27311619 DOI: 10.1016/j.cgh.2016.05.043] [Cited by in Crossref: 104] [Cited by in F6Publishing: 84] [Article Influence: 17.3] [Reference Citation Analysis]
250 Efe C, Simşek C, Batıbay E, Calışkan AR, Wahlin S. Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic. Expert Rev Gastroenterol Hepatol 2020;14:1215-9. [PMID: 32909852 DOI: 10.1080/17474124.2020.1822734] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
251 Cacciato V, Casagrande E, Bodini G, Furnari M, Marabotto E, Grillo F, Giannini EG. Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV. Ann Hepatol. 2020;19:222-225. [PMID: 32029393 DOI: 10.1016/j.aohep.2019.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
252 Korkmaz H, Bugdaci MS, Temel T, Dagli M, Karabagli P. Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome). Clin Res Hepatol Gastroenterol. 2013;37:e45-e50. [PMID: 23273499 DOI: 10.1016/j.clinre.2012.11.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
253 Czaja AJ. Challenges in the diagnosis and management of autoimmune hepatitis. Can J Gastroenterol 2013;27:531-9. [PMID: 24078938 DOI: 10.1155/2013/981086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
254 Abdollahi MR, Somi MH, Faraji E. Role of international criteria in the diagnosis of autoimmune hepatitis. World J Gastroenterol 2013; 19(23): 3629-3633 [PMID: 23801865 DOI: 10.3748/wjg.v19.i23.3629] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
255 Lee SJ, Lee YJ, Park KK. The pathogenesis of drug-induced liver injury. Expert Rev Gastroenterol Hepatol 2016;10:1175-85. [PMID: 27248313 DOI: 10.1080/17474124.2016.1196133] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
256 Björnsson E, Talwalkar J, Treeprasertsuk S, Neuhauser M, Lindor K. Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol. 2011;9:57-63. [PMID: 20723617 DOI: 10.1016/j.cgh.2010.07.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
257 Fujiwara K, Yasui S, Yokosuka O. Autoimmune acute liver failure: an emerging etiology for intractable acute liver failure. Hepatol Int 2013;7:335-46. [DOI: 10.1007/s12072-012-9402-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
258 Mahmud N, Doshi SD, Forde KA, Khungar V. Transient elastography reliably estimates liver fibrosis in autoimmune hepatitis. Clin Exp Hepatol 2019;5:244-9. [PMID: 31598562 DOI: 10.5114/ceh.2019.87639] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
259 Sebode M, Hartl J, Vergani D, Lohse AW; International Autoimmune Hepatitis Group (IAIHG). Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda. Liver Int 2018;38:15-22. [PMID: 28432836 DOI: 10.1111/liv.13458] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
260 Edmunds C, Ekong UD. Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research. Transplantation. 2016;100:515-524. [PMID: 26447505 DOI: 10.1097/tp.0000000000000922] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
261 Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D. Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev. 2014;13:435-440. [PMID: 24418295 DOI: 10.1016/j.autrev.2013.11.009] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 9.1] [Reference Citation Analysis]
262 Björnsson HK, Gudbjornsson B, Björnsson ES. Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment. J Hepatol 2021:S0168-8278(21)02022-5. [PMID: 34487751 DOI: 10.1016/j.jhep.2021.08.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
263 Lim TS, Kim JK. Is liver biopsy still useful in the era of non-invasive tests? Clin Mol Hepatol 2020;26:302-4. [PMID: 32646204 DOI: 10.3350/cmh.2020.0081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
264 Villalta D, Girolami E, Alessio MG, Sorrentino MC, Tampoia M, Brusca I, Daves M, Porcelli B, Barberio G, Conte M, Pantarotto L, Bizzaro N; Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine, Italy. Autoantibody Profiling in a Cohort of Pediatric and Adult Patients With Autoimmune Hepatitis. J Clin Lab Anal 2016;30:41-6. [PMID: 25242745 DOI: 10.1002/jcla.21813] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
265 Li Y, Peng M, Gong G. Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis. Exp Ther Med 2014;7:131-6. [PMID: 24348777 DOI: 10.3892/etm.2013.1366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
266 Schneider JS, Montani M, Stickel F. Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid. Case Rep Gastroenterol 2017;11:440-5. [PMID: 29033761 DOI: 10.1159/000479314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
267 Almaas R. Diagnosing autoimmune hepatitis in paediatric patients - we still haven't found what we are looking for. Acta Paediatr 2019;108:1562-3. [PMID: 31264728 DOI: 10.1111/apa.14890] [Reference Citation Analysis]
268 Yassin S, De Lacy R, Pillay K, Goddard E. Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa. J Trop Pediatr 2020;66:448-57. [PMID: 31943108 DOI: 10.1093/tropej/fmz088] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
269 Lombardi N, Crescioli G, Maggini V, Ippoliti I, Menniti-Ippolito F, Gallo E, Brilli V, Lanzi C, Mannaioni G, Firenzuoli F, Vannacci A. Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports. Br J Clin Pharmacol 2021;87:741-53. [PMID: 32656820 DOI: 10.1111/bcp.14460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
270 Czaja AJ. Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria. Gastroenterology. 2011;140:1472-1480. [PMID: 21324319 DOI: 10.1053/j.gastro.2011.02.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
271 Pratico AD, Salafia S, Barone P, La Rosa M, Leonardi S. Type II Autoimmune Hepatitis and Small Duct Sclerosing Cholangitis in a Seven Years Old Child: An Overlap Syndrome? Hepat Mon. 2013;13:e14452. [PMID: 24358042 DOI: 10.5812/hepatmon.14452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
272 Leung KK, Deeb M, Fischer SE, Gulamhusein A. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions. Semin Liver Dis 2021;41:409-20. [PMID: 34182588 DOI: 10.1055/s-0041-1730950] [Reference Citation Analysis]
273 Pape S, Gevers TJ, Belias M, Mustafajev IF, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CM, Hartl J, Schramm C, Lohse AW, Taubert R, Jaeckel E, Manns MP, Papp M, Stickel F, Heneghan MA, Drenth JP. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2019;17:2068-2075.e2. [DOI: 10.1016/j.cgh.2018.12.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 11.7] [Reference Citation Analysis]
274 Palacios Argueta P, Attar B, Sikavi C, Alagiozian-Angelova V, Mishra S. Drug-Induced Liver Injury Caused by "Khat," an Herbal Stimulant. ACG Case Rep J 2020;7:e00480. [PMID: 33299901 DOI: 10.14309/crj.0000000000000480] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
275 Behairy OG, El-shimi OS, Shalan NH, Baghdady SM. Association of the killer immunoglobulin-like receptor genes KIR2DS1 and KIR2DS4 with pediatric autoimmune hepatitis type I in Egypt. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00145-0] [Reference Citation Analysis]
276 Tanaka A, Harada K, Ebinuma H, Komori A, Yokokawa J, Yoshizawa K, Abe M, Miyake Y, Kikuchi K, Ohira H. Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan. Hepatol Res. 2011;41:877-886. [PMID: 21883738 DOI: 10.1111/j.1872-034x.2011.00844.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
277 Mendizabal M, Marciano S, Videla MG, Anders M, Zerega A, Balderramo DC, Chan D, Barrabino M, Gil O, Mastai R. Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina. Liver Transpl. 2014;20:483-489. [PMID: 24425668 DOI: 10.1002/lt.23823] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
278 Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, Baron U, Olek S, Wiegard C, Lohse AW, Weiler-Normann C, Schramm C, Herkel J. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol. 2012;57:125-132. [PMID: 22425700 DOI: 10.1016/j.jhep.2012.02.029] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 11.3] [Reference Citation Analysis]
279 Duseja A, Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S. Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci. 2010;55:3188-3192. [PMID: 20721624 DOI: 10.1007/s10620-010-1377-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
280 Yamagiwa S, Tamura Y, Takamura M, Genda T, Ichida T, Ishikawa T, Kamimura T, Takahashi T, Suda T, Matsuda Y, Nomoto M, Aoyagi Y. Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure. Hepatol Res 2014;44:E368-75. [PMID: 24612069 DOI: 10.1111/hepr.12318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
281 Zhu B, You SL, Wan ZH, Liu HL, Rong YH, Zang H, Xin SJ. Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure. World J Gastroenterol 2014; 20(23): 7473-7479 [PMID: 24966618 DOI: 10.3748/wjg.v20.i23.7473] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
282 Motawi TK, El-Maraghy SA, Sharaf SA, Said SE. Association of CARD10 rs6000782 and TNF rs1799724 variants with paediatric-onset autoimmune hepatitis. J Adv Res 2019;15:103-10. [PMID: 30581618 DOI: 10.1016/j.jare.2018.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
283 Mederacke YS, Kirstein MM, Großhennig A, Marhenke S, Metzler F, Manns MP, Vogel A, Mederacke I. The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. Aliment Pharmacol Ther 2020;51:1160-8. [PMID: 32323349 DOI: 10.1111/apt.15722] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
284 Zen Y, Yeh MM. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury. Mod Pathol. 2018;31:965-973. [PMID: 29403081 DOI: 10.1038/s41379-018-0013-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 27.5] [Reference Citation Analysis]
285 Nakayama S, Murashima N. Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis triggered by fluvastatin. Indian J Gastroenterol. 2011;30:97-99. [PMID: 21503830 DOI: 10.1007/s12664-011-0092-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
286 Salem B, Afef F, Nadia B, Nabil A, Maher B. [Portal vein thrombosis in a type 1 autoimmune hepatitis]. Pan Afr Med J 2013;14:130. [PMID: 23734275 DOI: 10.11604/pamj.2013.14.130.1435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
287 Pamecha V, Vagadiya A, Sinha PK, Sandhyav R, Parthasarathy K, Sasturkar S, Mohapatra N, Choudhury A, Maiwal R, Khanna R, Alam S, Pandey CK, Sarin SK. Living Donor Liver Transplantation for Acute Liver Failure: Donor Safety and Recipient Outcome. Liver Transpl. 2019;25:1408-1421. [PMID: 30861306 DOI: 10.1002/lt.25445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
288 Floreani A, Liberal R, Vergani D, Mieli-Vergani G. Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun. 2013;46:7-16. [PMID: 24035197 DOI: 10.1016/j.jaut.2013.08.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
289 Vergani D, Mieli-Vergani G. Cutting edge issues in autoimmune hepatitis. Clin Rev Allergy Immunol. 2012;42:309-321. [PMID: 21207191 DOI: 10.1007/s12016-010-8236-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
290 Rigopoulou EI, Zachou K, Gatselis NK, Papadamou G, Koukoulis GK, Dalekos GN. Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome. World J Hepatol 2013; 5(10): 577-583 [PMID: 24179617 DOI: 10.4254/wjh.v5.i10.577] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
291 Azariadis K, Gatselis NK, Koukoulis GK, Dalekos GN. Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus. BMJ Case Rep 2019;12:e228524. [PMID: 30898943 DOI: 10.1136/bcr-2018-228524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
292 Chow KW, Pham NV, Ibrahim BM, Hong K, Saab S. Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature. Dig Dis Sci 2022. [PMID: 35486203 DOI: 10.1007/s10620-022-07504-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Deswal S, Srivastava A. Role of Allopurinol in Optimizing Thiopurine Therapy in Patients with Autoimmune Hepatitis: A Review. J Clin Exp Hepatol 2017;7:55-62. [PMID: 28348471 DOI: 10.1016/j.jceh.2017.01.115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
294 Núñez Martínez Ó, Marquina Ibáñez I, Ruiz Bravo-Burguillos E, Encinas Sotillos A, Erdozaín Sosa JC. [Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome in a patient with chronic hepatitis B infection]. Gastroenterol Hepatol. 2013;36:382-387. [PMID: 23084258 DOI: 10.1016/j.gastrohep.2012.07.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
295 Weber S, Gerbes AL. Challenges and Future of Drug-Induced Liver Injury Research-Laboratory Tests. Int J Mol Sci 2022;23:6049. [PMID: 35682731 DOI: 10.3390/ijms23116049] [Reference Citation Analysis]
296 Liberal R, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: From mechanisms to therapy. Rev Clin Esp. 2016;216:372-383. [PMID: 27161382 DOI: 10.1016/j.rce.2016.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
297 Canivet CM, Anty R, Patouraux S, Saint-Paul MC, Lebeaupin C, Gual P, Duclos-Vallee JC, Tran A. Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries. Dig Liver Dis. 2016;48:302-308. [PMID: 26553036 DOI: 10.1016/j.dld.2015.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
298 Gao L, Li B, Wang J, Shen D, Yang M, Sun R, Tung HC, Xu M, Ren S, Zhang M, Yang D, Lu B, Wang H, Liu Y, Xie W. Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis. Hepatol Commun 2020;4:1664-79. [PMID: 33163836 DOI: 10.1002/hep4.1584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
299 Ilyas JA, O’Mahony CA, Vierling JM. Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol. 2011;25:765-782. [PMID: 22117641 DOI: 10.1016/j.bpg.2011.09.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
300 van Beers JJBC, Koek GH, Damoiseaux JGMC. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. J Appl Lab Med 2022;7:259-67. [PMID: 34996079 DOI: 10.1093/jalm/jfab099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Bedossa P, Garcia-Tsao G, Jain D. Cirrhosis Regression and Subclassification. Surg Pathol Clin 2013;6:295-309. [PMID: 26838976 DOI: 10.1016/j.path.2013.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
302 Weiler-Normann C, Lohse AW. Autoimmune hepatitis: from immunopathogenesis to diagnostic and therapeutic innovation. Curr Opin Gastroenterol 2021;37:86-90. [PMID: 33315793 DOI: 10.1097/MOG.0000000000000701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
303 Noda S, Asano Y, Tamaki Z, Takekoshi T, Sugaya M, Sato S. A case of dermatomyositis with "liver disease associated with rheumatoid diseases" positive for anti-liver-kidney microsome-1 antibody. Clin Rheumatol 2010;29:941-3. [PMID: 20179980 DOI: 10.1007/s10067-010-1397-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
304 Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent immunoassay technology: what does it change in autoantibody detection? Auto Immun Highlights 2017;8:9. [PMID: 28647912 DOI: 10.1007/s13317-017-0097-2] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 11.8] [Reference Citation Analysis]
305 Omori K, Yoshida K, Yokota M, Daa T, Kan M. Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter.Clin J Gastroenterol. 2016;9:312-318. [PMID: 27503128 DOI: 10.1007/s12328-016-0676-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
306 Rogowski JL, Verma MS, Chen PZ, Gu FX. A "chemical nose" biosensor for detecting proteins in complex mixtures. Analyst 2016;141:5627-36. [PMID: 27458615 DOI: 10.1039/c6an00729e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
307 Freedman BL, Danford CJ, Patwardhan V, Bonder A. Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E1449. [PMID: 32414025 DOI: 10.3390/jcm9051449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
308 Moreno-Otero R. Liver biopsy in the management of autoimmune hepatitis acute severe onset. Dig Dis Sci 2013;58:1808-9. [PMID: 23589142 DOI: 10.1007/s10620-013-2662-5] [Reference Citation Analysis]
309 Liu SP, Bian ZH, Zhao ZB, Wang J, Zhang W, Leung PSC, Li L, Lian ZX. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review. Clin Rev Allergy Immunol 2020;58:252-71. [PMID: 32076943 DOI: 10.1007/s12016-020-08778-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
310 Potts JR, Verma S. Optimizing management in autoimmune hepatitis with liver failure at initial presentation. World J Gastroenterol 2011; 17(16): 2070-2075 [PMID: 21547124 DOI: 10.3748/wjg.v17.i16.2070] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
311 Covelli C, Sacchi D, Sarcognato S, Cazzagon N, Grillo F, Baciorri F, Fanni D, Cacciatore M, Maffeis V, Guido M. Pathology of autoimmune hepatitis. Pathologica 2021;113:185-93. [PMID: 34294936 DOI: 10.32074/1591-951X-241] [Reference Citation Analysis]
312 Chaouali M, Azaiez MB, Tezeghdenti A, Lagha A, Yacoubi-Oueslati B, Ghazouani E, Abdallah HB, Kochkar R. Association of TNF-α-308 Polymorphism with Susceptibility to Autoimmune Hepatitis in Tunisians. Biochem Genet 2018;56:650-62. [PMID: 29845365 DOI: 10.1007/s10528-018-9867-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
313 Tanaka A, Ma X, Yokosuka O, Weltman M, You H, Amarapurkar DN, Kim YJ, Abbas Z, Payawal DA, Chang ML. Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016. Hepatol Int. 2016;10:909-915. [PMID: 27649967 DOI: 10.1007/s12072-016-9767-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
314 Andrade LEC, Damoiseaux J, Vergani D, Fritzler MJ. Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases. Journal of Translational Autoimmunity 2022. [DOI: 10.1016/j.jtauto.2022.100145] [Reference Citation Analysis]
315 Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci. 2011;56:545-554. [PMID: 21127976 DOI: 10.1007/s10620-010-1501-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
316 Guido M, Sarcognato S, Sonzogni A, Lucà MG, Senzolo M, Fagiuoli S, Ferrarese A, Pizzi M, Giacomelli L, Colloredo G. Obliterative portal venopathy without portal hypertension: an underestimated condition. Liver Int 2016;36:454-60. [PMID: 26264219 DOI: 10.1111/liv.12936] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
317 Czaja AJ. Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci. 2011;56:3421-3438. [PMID: 21647651 DOI: 10.1007/s10620-011-1769-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
318 Efe C, Purnak T, Ozaslan E. The Diagnostic Criteria for Patients With Autoimmune Hepatitis and Primary Biliary Cirrhosis Overlap Syndrome. Clinical Gastroenterology and Hepatology 2010;8:734. [DOI: 10.1016/j.cgh.2010.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
319 Than NN, Hodson J, Schmidt-Martin D, Taubert R, Wawman RE, Botter M, Gautam N, Bock K, Jones R, Appanna GD, Godkin A, Montano-Loza AJ, Lammert F, Schramm C, Manns MP, Swain M, Burak KW, Adams DH, Hirschfield GM, Oo YH. Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group. JHEP Rep 2019;1:437-45. [PMID: 32039395 DOI: 10.1016/j.jhepr.2019.10.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
320 Müller P, Messmer M, Bayer M, Pfeilschifter JM, Hintermann E, Christen U. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model. Journal of Autoimmunity 2016;69:51-8. [DOI: 10.1016/j.jaut.2016.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
321 Ngu JH, Gearry RB, Stedman CAM. Autoimmune Hepatitis in the East and the West. Inflamm Intest Dis 2017;1:147-9. [PMID: 29922670 DOI: 10.1159/000455177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
322 Murunga E, Andersson M, Rensburg Cv. Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients? Scand J Gastroenterol. 2016;51:814-818. [PMID: 27000683 DOI: 10.3109/00365521.2016.1157888] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
323 Yeoman AD, Westbrook RH, Zen Y, Bernal W, Al-Chalabi T, Wendon JA, O'Grady JG, Heneghan MA. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. J Hepatol 2014;61:876-82. [PMID: 24842305 DOI: 10.1016/j.jhep.2014.05.021] [Cited by in Crossref: 88] [Cited by in F6Publishing: 74] [Article Influence: 11.0] [Reference Citation Analysis]
324 Merli M, Gentili F, Giusto M, Attili AF, Corradini SG, Mennini G, Rossi M, Corsi A, Bianco P. Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis? Dig Liver Dis. 2009;41:345-349. [PMID: 19162574 DOI: 10.1016/j.dld.2008.09.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
325 Vergani D, Mieli-Vergani G. Autoimmune hepatitis: Diagnostic criteria and serological testing. Clin Liver Dis (Hoboken) 2014;3:38-41. [PMID: 31236268 DOI: 10.1002/cld.321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
326 Kawabata H, Kawakatsu Y, Inoue N, Okazaki Y, Sone D, Yamaguchi K, Ueda Y, Hitomi M, Miyata M, Motoi S, Enoki Y, Minamikawa T. IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology. Intern Med 2020;59:1401-5. [PMID: 32475907 DOI: 10.2169/internalmedicine.4092-19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
327 Makaritsis KP, Gatselis NK, Ioannou M, Petinaki E, Dalekos GN. Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis. Int J Infect Dis. 2009;13:e157-e160. [PMID: 19008139 DOI: 10.1016/j.ijid.2008.08.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
328 Zgair AK. Involvement of (IgG and IgM)-secreting B lymphocytes in severity of autoimmune hepatitis type 1. Med Microbiol Immunol 2013;202:229-37. [DOI: 10.1007/s00430-012-0287-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
329 Araki T, Arinaga-hino T, Koga H, Akiba J, Ide T, Okabe Y, Kuwahara R, Amano K, Yasumoto M, Kawaguchi T, Sano T, Kondou R, Kurata S, Mitsuyama K, Torimura T. Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis: Expression of FDG and Glut-3 in IgG4-related AIH. Hepatol Res 2018;48:937-44. [DOI: 10.1111/hepr.13188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
330 Yasui S, Fujiwara K, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis. Dig Dis Sci. 2011;56:3638-3647. [PMID: 21681505 DOI: 10.1007/s10620-011-1789-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
331 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
332 Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun. 2010;34:J300-J306. [PMID: 20036105 DOI: 10.1016/j.jaut.2009.12.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
333 Pan XL, Zhou YQ, Guo H, Ye J. Unexplained jaundice: Etiology, pathological features and diagnosis by liver biopsy. Shijie Huaren Xiaohua Zazhi 2014; 22(27): 4156-4161 [DOI: 10.11569/wcjd.v22.i27.4156] [Reference Citation Analysis]
334 Stickel F, Droz S, Patsenker E, Bögli-Stuber K, Aebi B, Leib SL. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol. 2009;50:111-117. [PMID: 19010564 DOI: 10.1016/j.jhep.2008.08.017] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
335 Dalekos GN, Gatselis NK. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases. Arch Immunol Ther Exp (Warsz) 2019;67:197-211. [PMID: 31165900 DOI: 10.1007/s00005-019-00550-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
336 Zavala-Flores E, Loja-Oropeza D. Rhupus and autoimmune hepatitis: A rare association. Reumatol Clin 2017;13:365-6. [PMID: 28347609 DOI: 10.1016/j.reuma.2017.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
337 Czaja AJ. Diagnosis and management of autoimmune hepatitis. Clin Liver Dis 2015;19:57-79. [PMID: 25454297 DOI: 10.1016/j.cld.2014.09.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
338 Teschke R. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin Drug Metab Toxicol. 2018;14:1169-1187. [PMID: 30354694 DOI: 10.1080/17425255.2018.1539077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
339 Kim BH, Kim YJ, Jeong SH, Tak WY, Ahn SH, Lee YJ, Jung EU, Lee JI, Yeon JE, Hwang JS, Um SH, Seo YS, Kim YS, Song BC, Kim JH, Jung YK, Park CK, Kim KA, Min HJ, Cho EY, Lee ES, Kwon SY, Chae HB, Kim DJ, Shin SR. Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study. J Gastroenterol Hepatol. 2013;28:128-134. [PMID: 23033899 DOI: 10.1111/j.1440-1746.2012.07292.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
340 Strassburg C, Manns M. Therapie der autoimmunen Lebererkrankungen: Autoimmune Hepatitis, primär sklerosierende Cholangitis. Internist 2011;52:1394-406. [DOI: 10.1007/s00108-011-2924-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
341 Björnsson ES, Gunnarsson BI, Gröndal G, Jonasson JG, Einarsdottir R, Ludviksson BR, Gudbjörnsson B, Olafsson S. Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists. Clinical Gastroenterology and Hepatology 2015;13:602-8. [DOI: 10.1016/j.cgh.2014.07.062] [Cited by in Crossref: 75] [Cited by in F6Publishing: 58] [Article Influence: 10.7] [Reference Citation Analysis]
342 Zachou K, Arvaniti P, Lyberopoulou A, Dalekos GN. Impact of genetic and environmental factors on autoimmune hepatitis. J Transl Autoimmun 2021;4:100125. [PMID: 34622188 DOI: 10.1016/j.jtauto.2021.100125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
343 Park Y, Cho Y, Cho EJ, Kim YJ. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes. Clin Mol Hepatol. 2015;21:150-157. [PMID: 26157752 DOI: 10.3350/cmh.2015.21.2.150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
344 Janmohamed A, Hirschfield GM. Autoimmune hepatitis and complexities in management. Frontline Gastroenterol 2019;10:77-87. [PMID: 30651962 DOI: 10.1136/flgastro-2018-101015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
345 Biewenga M, Farina Sarasqueta A, Tushuizen ME, de Jonge-Muller ESM, van Hoek B, Trouw LA. The role of complement activation in autoimmune liver disease. Autoimmun Rev 2020;19:102534. [PMID: 32234403 DOI: 10.1016/j.autrev.2020.102534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
346 Weinmann A, Sattler T, Unold HP, Grambihler A, Teufel A, Koch S, Schuchmann M, Biesterfeld S, Wörns MA, Galle PR. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients. J Clin Gastroenterol. 2015;49:438-447. [PMID: 25014239 DOI: 10.1097/mcg.0000000000000176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
347 Łapiński TW, Rogalska-Płońska M, Parfieniuk-Kowerda A, Świderska M, Flisiak R. The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation. Clin Exp Hepatol 2016;2:161-6. [PMID: 28856282 DOI: 10.5114/ceh.2016.63874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
348 Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLoS One. 2018;13:e0209352. [PMID: 30571774 DOI: 10.1371/journal.pone.0209352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
349 Ko BJ, Kim YS, Kim SG, Park JH, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS, Kim SM. Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease. Gut Liver. 2016;10:818-825. [PMID: 27114415 DOI: 10.5009/gnl15331] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
350 Chen RL, Wang QX, Ma X. Precision medicine for autoimmune hepatitis. J Dig Dis 2019;20:331-7. [PMID: 31099976 DOI: 10.1111/1751-2980.12786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
351 Restellini S, Chazouillères O, Frossard JL. Hepatic manifestations of inflammatory bowel diseases. Liver Int 2017;37:475-89. [PMID: 27712010 DOI: 10.1111/liv.13265] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
352 Alqrinawi SH, Akbar N, AlFaddag H, Akbar S, Akbar L, Butt SA, Aljawad M. Menotrophin Induced Autoimmune Hepatitis. Case Rep Gastrointest Med 2019;2019:7343805. [PMID: 31565446 DOI: 10.1155/2019/7343805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
353 Gomes NBN, Torres US, Ferraz MLCG, D'Ippolito G. Autoimmune hepatitis in practice, from diagnosis to complications: What is the role of imaging? A clinicoradiological review. Clin Imaging 2021;74:31-40. [PMID: 33429144 DOI: 10.1016/j.clinimag.2020.12.032] [Reference Citation Analysis]
354 Hu M, You Z, Li Y, Huang B, Cui N, Wang R, Wei Y, Li B, Liang J, Liu Q, Li Y, Wang H, Qian Q, Zhang J, Chen R, Lyu Z, Chen Y, Xiao X, Lian M, Tang R, Miao Q, Wang Q, Ma X. Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the Literature. Clin Rev Allergy Immunol 2022. [PMID: 35657576 DOI: 10.1007/s12016-022-08935-z] [Reference Citation Analysis]
355 Gao SJ, Xu Y, Bao J, Liu X, Liu XM, Hua J. Diagnosis and treatment of trigeminy overlap syndrome of autoimmune liver disease. Shijie Huaren Xiaohua Zazhi 2016; 24(2): 293-299 [DOI: 10.11569/wcjd.v24.i2.293] [Reference Citation Analysis]
356 Fallatah HI, Akbar HO. Autoimmune liver disease - are there spectra that we do not know? Comp Hepatol. 2011;10:9. [PMID: 21910861 DOI: 10.1186/1476-5926-10-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
357 Göke A, Göke B. [Diseases in gastroenterology]. Internist (Berl) 2013;54:1185-96. [PMID: 24026789 DOI: 10.1007/s00108-013-3290-z] [Reference Citation Analysis]
358 Kumar N, Poddar U, Yadav R, Lal H, Pani K, Yachha SK, Srivastava A, Pandey R. Autoimmune Sclerosing Cholangitis in Children: A Prospective Case-Control Study. Pediatr Gastroenterol Hepatol Nutr 2021;24:154-63. [PMID: 33833971 DOI: 10.5223/pghn.2021.24.2.154] [Reference Citation Analysis]
359 Dong Y, Potthoff A, Klinger C, Barreiros AP, Pietrawski D, Dietrich CF. Ultrasound findings in autoimmune hepatitis. World J Gastroenterol 2018; 24(15): 1583-1590 [PMID: 29686465 DOI: 10.3748/wjg.v24.i15.1583] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
360 van Gemeren MA, van Wijngaarden P, Doukas M, de Man RA. Vaccine-related autoimmune hepatitis: the same disease as idiopathic autoimmune hepatitis? Two clinical reports and review. Scand J Gastroenterol. 2017;52:18-22. [PMID: 27565372 DOI: 10.1080/00365521.2016.1224379] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
361 Lotfy A, Elgamal A, Burdzinska A, Swelum AA, Soliman R, Hassan AA, Shiha G. Stem cell therapies for autoimmune hepatitis. Stem Cell Res Ther 2021;12:386. [PMID: 34233726 DOI: 10.1186/s13287-021-02464-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Goyes D, Malladi VR, Ishtiaq R, Al-Khazraji A. Case of autoimmune hepatitis with overlap systemic lupus erythematosus. BMJ Case Rep 2020;13:e237341. [PMID: 33376090 DOI: 10.1136/bcr-2020-237341] [Reference Citation Analysis]
363 Puustinen L, Barner-Rasmussen N, Pukkala E, Färkkilä M. Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland. Dig Liver Dis 2019;51:1294-9. [PMID: 30850346 DOI: 10.1016/j.dld.2019.01.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
364 Hardtke-Wolenski M, Fischer K, Noyan F, Schlue J, Falk CS, Stahlhut M, Woller N, Kuehnel F, Taubert R, Manns MP, Jaeckel E. Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells. Hepatology 2013;58:718-28. [PMID: 23475565 DOI: 10.1002/hep.26380] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
365 Chaiteerakij R, Sanpawat A, Avihingsanon A, Treeprasertsuk S. Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature. World J Gastroenterol 2019; 25(35): 5388-5402 [PMID: 31558881 DOI: 10.3748/wjg.v25.i35.5388] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
366 Muñoz-Espinosa L, Alarcon G, Mercado-Moreira A, Cordero P, Caballero E, Avalos V, Villarreal G, Senties K, Puente D, Soto J, Esqueda B, Campos G, Martínez M, Jaquez J, Ramirez A, Reyes I, Kershenobich D, Montano-Loza AJ. Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients. Autoimmunity 2011;44:543-8. [PMID: 21875376 DOI: 10.3109/08916934.2011.592884] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
367 Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016;75:6-19. [PMID: 27502148 DOI: 10.1016/j.jaut.2016.07.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 9.7] [Reference Citation Analysis]
368 Tanaka A. Acute presentation of autoimmune hepatitis: How to find and manage still remains unsolved. Hepatol Res 2013;43:577-9. [PMID: 23730706 DOI: 10.1111/hepr.12031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
369 Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, Torimura T, Yoshizawa K, Takaki A, Kang JH, Suzuki Y, Nakamoto N, Inui A, Tanaka A, Takikawa H. Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan. Sci Rep 2020;10:14250. [PMID: 32859968 DOI: 10.1038/s41598-020-71296-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
370 Schrumpf E, Boberg KM, Karlsen TH. Primary sclerosing cholangitis - the Norwegian experience. Scand J Gastroenterol 2015;50:781-96. [PMID: 25866138 DOI: 10.3109/00365521.2015.1028996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
371 Czaja AJ. Review article: the management of autoimmune hepatitis beyond consensus guidelines. Aliment Pharmacol Ther 2013;38:343-64. [DOI: 10.1111/apt.12381] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
372 Dara N, Imanzadeh F, Sayyari AA, Nasri P, Hosseini AH. Simultaneous Presentation of Wilson's Disease and Autoimmune Hepatitis; A Case Report and Review of Literature. Hepat Mon 2015;15:e29043. [PMID: 26288636 DOI: 10.5812/hepatmon.29043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
373 Ohira H, Takahashi A. Current trends in the diagnosis and treatment of autoimmune hepatitis in Japan. Hepatol Res. 2012;42:131-138. [PMID: 22044759 DOI: 10.1111/j.1872-034X.2011.00904.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
374 Liwinski T, Heinemann M, Schramm C. The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts. Semin Immunopathol 2022. [PMID: 35536431 DOI: 10.1007/s00281-022-00936-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
375 Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut Liver. 2016;10:177-203. [PMID: 26934884 DOI: 10.5009/gnl15352] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 13.7] [Reference Citation Analysis]
376 Abe K, Takahashi A, Sato Y, Okai K, Katsushima F, Monoe K, Kanno Y, Saito H, Ohira H. Case of idiopathic portal hypertension complicated with autoimmune hepatitis. Hepatol Res. 2013;43:984-990. [PMID: 23675841 DOI: 10.1111/hepr.12038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
377 Roggenbuck D, Mytilinaiou MG, Lapin SV, Reinhold D, Conrad K. Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity. Auto Immun Highlights 2012;3:119-25. [PMID: 26000135 DOI: 10.1007/s13317-012-0041-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
378 Lamba M, Ngu JH, Stedman CA. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2021;19:573-579.e1. [DOI: 10.1016/j.cgh.2020.05.061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
379 Yan M, Yang J, Sun Q, Liu C, Wang Y, Wang W. Hepatocellular carcinoma that arose from primary Sjögren’s syndrome. Annals of Hepatology 2013;12:824-9. [DOI: 10.1016/s1665-2681(19)31327-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
380 Liu Y, Yan W, Yuan W, Wang P, Huang D, Luo X, Ning Q. Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis. Clinical Immunology 2019;198:79-88. [DOI: 10.1016/j.clim.2018.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
381 Sener AG. Autoantibodies in autoimmune liver diseases. APMIS 2015;123:915-9. [DOI: 10.1111/apm.12442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
382 Li B, Lian M, Li Y, Qian Q, Zhang J, Liu Q, Tang R, Ma X. Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor α Protected From Autoimmune Hepatitis. Front Immunol 2021;12:732102. [PMID: 34512667 DOI: 10.3389/fimmu.2021.732102] [Reference Citation Analysis]
383 Choi G, Peters MG. The challenge of diagnosing autoimmune hepatitis: less is more. Hepatology 2008;48:10-2. [PMID: 18571784 DOI: 10.1002/hep.22438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
384 Olsen K, Hodson J, Ronca V, Bozward AG, Hayden J, Wootton G, Armstrong M, Adams DH, El-Sherif O, Ferguson J, Knox E, Johnston T, Thompson F, Oo YH. Type 2 Autoimmune Hepatitis and Nonadherence to Medication Correlate With Premature Birth and Risk of Postpartum Flare. Hepatol Commun 2021;5:1252-64. [PMID: 34278173 DOI: 10.1002/hep4.1714] [Reference Citation Analysis]
385 Vallejo Senra N, Fernández Castroagudín J, Molina Pérez E, Domínguez-Muñoz JE. [Onset of severe acute autoimmune hepatitis refractory to conventional treatment, rescued with infliximab]. Gastroenterol Hepatol 2014;37:524-6. [PMID: 24709334 DOI: 10.1016/j.gastrohep.2014.02.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
386 Trivedi PJ, Hirschfield GM. Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther. 2012;36:517-533. [PMID: 22817525 DOI: 10.1111/j.1365-2036.2012.05223.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 65] [Article Influence: 9.3] [Reference Citation Analysis]
387 Gaber Y, AbdAllah M, Salama A, Sayed M, Abdel Alem S, Nafady S. Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction. Expert Rev Gastroenterol Hepatol 2021;:1-9. [PMID: 34263707 DOI: 10.1080/17474124.2021.1952867] [Reference Citation Analysis]
388 Huang C, Shen Y, Shen M, Fan X, Men R, Ye T, Yang L. Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis. Front Pharmacol 2021;12:726128. [PMID: 34531750 DOI: 10.3389/fphar.2021.726128] [Reference Citation Analysis]
389 Liaskos C, Norman GL, Moulas A, Garagounis A, Goulis I, Rigopoulou EI, Dalekos GN. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clinica Chimica Acta 2010;411:411-5. [DOI: 10.1016/j.cca.2009.12.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
390 Liberal R, Vergani D, Mieli-Vergani G. Update on Autoimmune Hepatitis. J Clin Transl Hepatol. 2015;3:42-52. [PMID: 26357634 DOI: 10.14218/jcth.2014.00032] [Cited by in Crossref: 58] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
391 Vajro P, Maddaluno S, Veropalumbo C. Persistent hypertransaminasemia in asymptomatic children: A stepwise approach. World J Gastroenterol 2013; 19(18): 2740-2751 [PMID: 23687411 DOI: 10.3748/wjg.v19.i18.2740] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
392 Mitra S, Minz RW. Autoantibodies in Autoimmune Liver Diseases-Methods of Detection and Interpretation: An Update for the Reporting Pathologist. Int J Surg Pathol 2016;24:576-85. [PMID: 27388199 DOI: 10.1177/1066896916657643] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
393 Moreton FC, Brenner R, Lazarus J, Davenport R. Clinicopathological case: progressive cognitive decline with gait disturbance in a steel worker. Pract Neurol 2017;17:159-66. [PMID: 27927776 DOI: 10.1136/practneurol-2016-001527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
394 Washington MK, Manns MP. Autoimmune hepatitis. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 467-90. [DOI: 10.1016/b978-0-7020-3398-8.00009-x] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
395 Schiano TD, Fiel MI. To B(iopsy) or not to B(iopsy) …. Clin Gastroenterol Hepatol. 2011;9:3-4. [PMID: 20951834 DOI: 10.1016/j.cgh.2010.09.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
396 Puustinen L, Boyd S, Mustonen H, Arkkila P, Arola J, Färkkilä M. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis. Scandinavian Journal of Gastroenterology 2017;52:321-7. [DOI: 10.1080/00365521.2016.1253768] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
397 Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, Fritzler MJ, Herold M, Mimori T, Satoh M, Andrade LE, Chan EK, Conrad K. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights 2016;7:1. [PMID: 26831867 DOI: 10.1007/s13317-016-0075-0] [Cited by in F6Publishing: 55] [Reference Citation Analysis]
398 Saitis A, Gatselis N, Zachou K, Dalekos GN. Use of TNFα antagonists in refractory AIH: revealing the unforeseen. J Hepatol. 2013;59:197-198. [PMID: 23528379 DOI: 10.1016/j.jhep.2013.02.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
399 Jothimani D, Cramp ME, Cross TJ. Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study. J Clin Exp Hepatol. 2014;4:221-225. [PMID: 25755564 DOI: 10.1016/j.jceh.2014.05.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
400 Wirth S. Autoimmune Lebererkrankungen. Monatsschr Kinderheilkd 2010;158:1077-85. [DOI: 10.1007/s00112-010-2234-0] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
401 Wang ZW, Wang Y, Wang BY, Ding YY, Li JP, Ma L, Zhang H. Clinical features of autoimmune liver disease. Shijie Huaren Xiaohua Zazhi 2011; 19(15): 1568-1573 [DOI: 10.11569/wcjd.v19.i15.1568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Damasceno JX, Guedes MIF, Leite CAC, Monteiro AJ, Fonteles MC, Jimenez MEZ, de Lima V, Ribeiro TR, Fonteles CSR. Salivary immunoglobulin levels in juvenile autoimmune hepatitis. Archives of Oral Biology 2018;92:51-6. [DOI: 10.1016/j.archoralbio.2018.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
403 Behairy OG, Behiry EG, El Defrawy MS, El Adly AN. Diagnostic value of soluble programmed cell death protein-1 in type-1 autoimmune hepatitis in Egyptian children. Scandinavian Journal of Clinical and Laboratory Investigation 2020;80:59-65. [DOI: 10.1080/00365513.2019.1695283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
404 Grasland A, Sterpu R, Boussoukaya S, Mahe I. Autoimmune hepatitis induced by adalimumab with successful switch to abatacept. Eur J Clin Pharmacol. 2012;68:895-898. [PMID: 22205272 DOI: 10.1007/s00228-011-1191-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
405 Kirstein MM, Metzler F, Geiger E, Heinrich E, Hallensleben M, Manns MP, Vogel A. Prediction of short- and long-term outcome in patients with autoimmune hepatitis. Hepatology 2015;62:1524-35. [PMID: 26178791 DOI: 10.1002/hep.27983] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 11.4] [Reference Citation Analysis]
406 Milkiewicz P, Krawczyk M, Wunsch E, Ponsioen C, Hirschfield GM, Hubscher SG. Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management. Hepatol Commun 2020;4:399-408. [PMID: 32140656 DOI: 10.1002/hep4.1467] [Reference Citation Analysis]
407 Christen U. The role of autoantibodies in autoimmune hepatitis type 2. Immunotherapy 2013;5:247-56. [DOI: 10.2217/imt.13.5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
408 Lukefahr AL, McEvoy S, Alfafara C, Funk JL. Drug-induced autoimmune hepatitis associated with turmeric dietary supplement use. BMJ Case Rep 2018;2018:bcr-2018-224611. [PMID: 30206065 DOI: 10.1136/bcr-2018-224611] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
409 Sandusadee N, Sukeepaisarnjaroen W, Suttichaimongkol T. Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis. Heliyon 2020;6:e03767. [PMID: 32382677 DOI: 10.1016/j.heliyon.2020.e03767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
410 Couto CA, Terrabuio DRB, Cançado ELR, Porta G, Levy C, Silva AEB, Bittencourt PL, Carvalho Filho RJD, Chaves DM, Miura IK, Codes L, Faria LC, Evangelista AS, Farias AQ, Gonçalves LL, Harriz M, Lopes EPDA, Luz GO, Oliveira PMC, Oliveira EMG, Schiavon JLN, Sevá-pereira T. UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER. Arq Gastroenterol 2019;56:232-41. [DOI: 10.1590/s0004-2803.201900000-43] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
411 Matsumoto K, Miyake Y, Matsushita H, Ohnishi A, Ikeda F, Shiraha H, Takaki A, Nouso K, Yamamoto K. Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis. J Gastroenterol Hepatol. 2013; Jul 22. [Epub ahead of print]. [PMID: 23869988 DOI: 10.1111/jgh.12340] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
412 Li J, Han T, Zhao ZG, Zhou SF. Clinical features of autoimmune hepatitis in patients positive for hepatitis B virus markers. Shijie Huaren Xiaohua Zazhi 2014; 22(21): 3127-3132 [DOI: 10.11569/wcjd.v22.i21.3127] [Reference Citation Analysis]
413 Oliveira LC, Porta G, Marin ML, Bittencourt PL, Kalil J, Goldberg AC. Autoimmune hepatitis, HLA and extended haplotypes. Autoimmun Rev. 2011;10:189-193. [PMID: 20933106 DOI: 10.1016/j.autrev.2010.09.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
414 García Juárez I, Miquel R, Forns X, Bruguera M. [Levofloxacin-induced autoimmune hepatitis. Description of a case]. Gastroenterol Hepatol 2014;37:46-8. [PMID: 24094621 DOI: 10.1016/j.gastrohep.2013.07.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
415 Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep 2020;2:100149. [PMID: 32995712 DOI: 10.1016/j.jhepr.2020.100149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
416 Zipprich A. Rheumatologie und Hepatologie: Diagnostik und Therapie von autoimmunen Lebererkrankungen. Aktuelle Rheumatologie 2021;46:457-64. [DOI: 10.1055/a-0885-9314] [Reference Citation Analysis]
417 Safar Zadeh E, Lungu AO, Cochran EK, Brown RJ, Ghany MG, Heller T, Kleiner DE, Gorden P. The liver diseases of lipodystrophy: the long-term effect of leptin treatment. J Hepatol. 2013;59:131-137. [PMID: 23439261 DOI: 10.1016/j.jhep.2013.02.007] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 10.7] [Reference Citation Analysis]
418 Czaja AJ. Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management. Expert Rev Gastroenterol Hepatol 2018;12:547-64. [PMID: 29540068 DOI: 10.1080/17474124.2018.1453356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
419 Czaja AJ. Cholestatic phenotypes of autoimmune hepatitis. Clin Gastroenterol Hepatol 2014;12:1430-8. [PMID: 24013108 DOI: 10.1016/j.cgh.2013.08.039] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
420 Abdel-Ghaffar TY, Sira MM, Sira AM, Salem TA, El-Sharawy AA, El Naghi S. Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation. Eur J Gastroenterol Hepatol. 2015;27:1161-1169. [PMID: 26062080 DOI: 10.1097/meg.0000000000000413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
421 Sarda G, Harvey R. Severe transaminitis in a paediatric patient with systemic lupus erythaematosus and a discussion of the literature. BMJ Case Rep 2016;2016:10.1136/bcr-2015-214159. [PMID: 27090540 DOI: 10.1136/bcr-2015-214159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
422 Bovensiepen CS, Schakat M, Sebode M, Zenouzi R, Hartl J, Peiseler M, Li J, Henze L, Woestemeier A, Schramm C, Lohse AW, Herkel J, Weiler-Normann C. TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis. J Immunol 2019;203:3148-56. [PMID: 31685647 DOI: 10.4049/jimmunol.1900124] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
423 Andrade RJ, Robles‐díaz M. Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice. Liver Int 2019;40:6-17. [DOI: 10.1111/liv.14271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
424 Yim SH, Hong D, Jung KE, Seo YJ, Lee Y. Hypertrichosis Lanuginosa Acquisita Associated with Autoimmune Hepatitis. Ann Dermatol 2021;33:200-2. [PMID: 33935467 DOI: 10.5021/ad.2021.33.2.200] [Reference Citation Analysis]
425 Björnsson ES, Medina-Caliz I, Andrade RJ, Lucena MI. Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports. Hepatol Commun 2022. [PMID: 35596597 DOI: 10.1002/hep4.1959] [Reference Citation Analysis]
426 Wobser H, Paur T, Schnoy E, Hartl J, Kirchner GI. Suitability of the simplified autoimmune hepatitis score for the diagnosis of autoimmune hepatitis in a German cohort. United European Gastroenterol J 2018;6:247-54. [PMID: 29511554 DOI: 10.1177/2050640617711632] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
427 Sirbe C, Simu G, Szabo I, Grama A, Pop TL. Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms. Int J Mol Sci 2021;22:13578. [PMID: 34948375 DOI: 10.3390/ijms222413578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
428 Peña-Vélez R, Almanza-Miranda E. [Autoimmune hepatitis in the pediatric age]. Bol Med Hosp Infant Mex 2017;74:324-33. [PMID: 29382475 DOI: 10.1016/j.bmhimx.2017.05.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
429 Christen U, Hintermann E. Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models? Int J Mol Sci 2016;17:E2007. [PMID: 27916939 DOI: 10.3390/ijms17122007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
430 Chen C, Ho M, Wu J, Jeng Y, Chen H, Chang M, Lee P, Hu R, Ni Y. Development of autoantibodies after pediatric liver transplantation. Pediatr Transplantation 2013;17:144-8. [DOI: 10.1111/petr.12032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
431 Zachou K, Muratori P, Koukoulis GK, Granito A, Gatselis N, Fabbri A, Dalekos GN, Muratori L. Review article: autoimmune hepatitis -- current management and challenges. Aliment Pharmacol Ther. 2013;38:887-913. [PMID: 24010812 DOI: 10.1111/apt.12470] [Cited by in Crossref: 110] [Cited by in F6Publishing: 95] [Article Influence: 12.2] [Reference Citation Analysis]
432 Hisamochi A, Kage M, Arinaga T, Ide T, Miyajima I, Ogata K, Kuwahara R, Koga Y, Kumashiro R, Sata M. Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis. Clin J Gastroenterol 2013;6:139-44. [PMID: 26181451 DOI: 10.1007/s12328-013-0359-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
433 Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 2015; 21(1): 60-83 [PMID: 25574080 DOI: 10.3748/wjg.v21.i1.60] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 76] [Article Influence: 11.9] [Reference Citation Analysis]
434 Santos OM, Muñoz Ortiz E, Pérez C, Restrepo JC. [Autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome in adults: report of three cases]. Gastroenterol Hepatol 2012;35:254-8. [PMID: 22284044 DOI: 10.1016/j.gastrohep.2011.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
435 Muñoz-Espinosa LE, Cordero-Pérez P, Cura-Esquivel I, Torres-González L, Zuñiga-Noriega J. Autoimmune hepatitis in Mexican patients. J Clin Gastroenterol 2013;47:372. [PMID: 23388846 DOI: 10.1097/MCG.0b013e318276bf15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
436 Macaluso FS, Alessi N, Cabibi D. Antimitochondrial antibody -M2 positive autoimmune hepatitis during standard of care for chronic hepatitis C. Hepatol Res 2012;42:428-32. [PMID: 22443693 DOI: 10.1111/j.1872-034X.2011.00931.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
437 Suzuki H, Harada S, Takao S, Takahashi M, Kato M, Kotoh K. Low-grade elevation of fibrinogen-degradation products is an important parameter to identify acute presentation of autoimmune hepatitis. Scand J Gastroenterol 2016;51:986-93. [PMID: 27161820 DOI: 10.3109/00365521.2016.1168865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
438 Czaja AJ. Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Dig Dis Sci. 2017;62:2277-2292. [PMID: 28710658 DOI: 10.1007/s10620-017-4675-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
439 Muratori P, Efe C, Muratori L, Ozaslan E, Schiano T, Yoshida EM, Heurgué-berlot A, Lalanne C, Lenzi M, Wahlin S. Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. European Journal of Gastroenterology & Hepatology 2017;29:777-80. [DOI: 10.1097/meg.0000000000000870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
440 Lin R, Zhang J, Zhou L, Wang B. Altered function of monocytes/macrophages in patients with autoimmune hepatitis. Mol Med Rep 2016;13:3874-80. [PMID: 26986756 DOI: 10.3892/mmr.2016.4998] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
441 Almogairen SM. Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in mice. BMC Pharmacol Toxicol 2019;20:26. [PMID: 31064410 DOI: 10.1186/s40360-019-0303-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
442 Mieli-Vergani G, Vergani D. Paediatric autoimmune liver disease. Arch Dis Child. 2013;98:1012-1017. [PMID: 24001955 DOI: 10.1136/archdischild-2013-303848] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
443 Yoshioka Y, Taniai M, Hashimoto E, Haruta I, Shiratori K. Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy. Hepatol Res 2014;44:947-55. [PMID: 23879195 DOI: 10.1111/hepr.12210] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
444 Candia R, Norero B, Agüero C, Díaz L, Ortega JP, Wolff R, Hernández-Rocha C, Duarte I, Soza A, Benítez C, Arrese M. Validation of the Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Chilean-Hispanic Patients. Ann Hepatol 2017;16:772-9. [PMID: 28809732 DOI: 10.5604/01.3001.0010.2787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
445 Castiella A, Zapata E, Lucena MI, Andrade RJ. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease. World J Hepatol 2014; 6(4): 160-168 [PMID: 24799984 DOI: 10.4254/wjh.v6.i4.160] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 8.5] [Reference Citation Analysis]
446 Durazzo M, Premoli A, Paschetta E, Belci P, Spandre M, Bo S. Overlap syndromes of autoimmune hepatitis: an open question. Dig Dis Sci. 2013;58:344-348. [PMID: 23086110 DOI: 10.1007/s10620-012-2378-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
447 Lim SZ, Chuah KH, Rajaram RB, Stanley K, Shahrani S, Chan WK, Ho SH, Hilmi IN, Goh KL, Mahadeva S. Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study. J Gastroenterol Hepatol 2022. [PMID: 35637160 DOI: 10.1111/jgh.15905] [Reference Citation Analysis]
448 Zhang WC, Zhao FR, Chen J, Chen WX. Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis. PLoS One. 2014;9:e92267. [PMID: 24651126 DOI: 10.1371/journal.pone.0092267] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
449 Primo J, Michavila J, Jiménez I. Efalizumab-induced autoimmune hepatitis. Gastroenterol Hepatol. 2010;33:69-70. [PMID: 19800148 DOI: 10.1016/j.gastrohep.2009.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
450 Abo-Haded HM, Barakat TS, Hafez MM. Myocardial performance in children with autoimmune hepatitis: Doppler tissue imaging study. Eur J Pediatr 2013;172:1511-9. [PMID: 23812510 DOI: 10.1007/s00431-013-2073-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
451 Ahmed A, Ali H, Galan M, Jiang JG, Lingiah V. Concurrent Langerhans Cell Histiocytosis and Autoimmune Hepatitis: A Case and Review of the Literature. Cureus 2020;12:e11808. [PMID: 33409053 DOI: 10.7759/cureus.11808] [Reference Citation Analysis]
452 Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK. Immune-mediated diseases in primary sclerosing cholangitis. Dig Liver Dis. 2011;43:802-806. [PMID: 21700515 DOI: 10.1016/j.dld.2011.05.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
453 Vergani D, Longhi MS, Bogdanos DP, Ma Y, Mieli-Vergani G. Autoimmune hepatitis. Semin Immunopathol. 2009;31:421-435. [PMID: 19533129 DOI: 10.1007/s00281-009-0170-7] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
454 Hadzic N, Hierro L. Autoimmune liver disease: novelties in management. Clin Res Hepatol Gastroenterol. 2014;38:273-276. [PMID: 24767608 DOI: 10.1016/j.clinre.2014.03.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
455 Gatselis NK, Zachou K, Papamichalis P, Koukoulis GK, Gabeta S, Dalekos GN, Rigopoulou EI. Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: A new or a complementary diagnostic score? Digestive and Liver Disease 2010;42:807-12. [DOI: 10.1016/j.dld.2010.03.005] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
456 Kleiner DE. Drug-induced Liver Injury: The Hepatic Pathologist's Approach. Gastroenterol Clin North Am 2017;46:273-96. [PMID: 28506365 DOI: 10.1016/j.gtc.2017.01.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
457 Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci. 2015;17:14. [PMID: 26712744 DOI: 10.3390/ijms17010014] [Cited by in Crossref: 256] [Cited by in F6Publishing: 226] [Article Influence: 36.6] [Reference Citation Analysis]
458 Xiang D, Xia Q, Chen D, Feng X, Zhao Y, Liu Y, Liao H, Liu Y, Li N, Yan H. Detection of D-3-phosphoglycerate dehydrogenase autoantibodies in patients with autoimmune hepatitis: Clinical significance evaluation. Hepatol Res 2011;41:867-76. [PMID: 21707887 DOI: 10.1111/j.1872-034X.2011.00839.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
459 Antunes H, Rocha R, Silva N, Pontes T, Antunes A, Martins S. Immune disease expressed in liver and platelets in an adolescent: a case report. Ital J Pediatr 2010;36:42. [PMID: 20540743 DOI: 10.1186/1824-7288-36-42] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
460 Terziroli Beretta-Piccoli B, Vergani D, Mieli-Vergani G. Autoimmune sclerosing cholangitis: Evidence and open questions. J Autoimmun 2018;95:15-25. [PMID: 30366655 DOI: 10.1016/j.jaut.2018.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
461 徐征宇, 陈吉. 自身免疫性肝炎的相关进展. 世界华人消化杂志 2017; 25(16): 1475-1479 [DOI: 10.11569/wcjd.v25.i16.1475] [Reference Citation Analysis]
462 Takahashi A, Arinaga-Hino T, Ohira H, Torimura T, Zeniya M, Abe M, Yoshizawa K, Takaki A, Suzuki Y, Kang JH, Nakamoto N, Fujisawa T, Yonemoto K, Tanaka A, Takikawa H; Autoimmune Hepatitis Study Group-Subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan. Autoimmune hepatitis in Japan: trends in a nationwide survey. J Gastroenterol. 2017;52:631-640. [PMID: 27722997 DOI: 10.1007/s00535-016-1267-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
463 Aljumah AA, Al-ashgar H, Fallatah H, Albenmousa A. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes. Annals of Hepatology 2019;18:439-44. [DOI: 10.1016/j.aohep.2018.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Licata A, Maida M, Cabibi D, Butera G, Macaluso FS, Alessi N, Caruso C, Craxì A, Almasio PL. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study. Dig Liver Dis 2014;46:1116-20. [PMID: 25224696 DOI: 10.1016/j.dld.2014.08.040] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
465 Yousefi A, Najafi M, Motamed F, Mahmoudi E, Bidoki AZ, Sadr M, Rahmani F, Farhmand F, Khodadad A, Fallahi G, Rezaei N. Association of Interleukin-6 and Interleukin-1 Family Gene Polymorphisms in Autoimmune Hepatitis. Annals of Hepatology 2018;17:1021-5. [DOI: 10.5604/01.3001.0012.7202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
466 Li Y, Xiao X, Miao Q, Ma X. Rapid response predicts complete biochemical response and histological remission in autoimmune hepatitis. J Hepatol 2022:S0168-8278(22)02945-2. [PMID: 35870704 DOI: 10.1016/j.jhep.2022.07.012] [Reference Citation Analysis]
467 Muratori P, Granito A, Pappas G, Muratori L. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology 2009;49:1782-3; author reply 1783. [PMID: 19402135 DOI: 10.1002/hep.22825] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
468 Lucena MI, Kaplowitz N, Hallal H, Castiella A, García-Bengoechea M, Otazua P, Berenguer M, Fernandez MC, Planas R, Andrade RJ. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis. J Hepatol. 2011;55:820-827. [PMID: 21338638 DOI: 10.1016/j.jhep.2010.12.041] [Cited by in Crossref: 69] [Cited by in F6Publishing: 55] [Article Influence: 6.3] [Reference Citation Analysis]
469 Lüth S, Weiler-Normann C, Schramm C, Lohse AW. [Autoimmune liver diseases]. Internist (Berl). 2009;50:310-317. [PMID: 19225747 DOI: 10.1007/s00108-008-2254-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
470 Flatley S, Dube AK, Gleeson D. Histopathologist and clinician interface in diagnosis and management of autoimmune hepatitis. Frontline Gastroenterol 2022;13:e94-e101. [DOI: 10.1136/flgastro-2022-102192] [Reference Citation Analysis]
471 Sokollik C, Mclin VA, Vergani D, Terziroli Beretta-piccoli B, Mieli-vergani G. Juvenile autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2018;95:69-76. [DOI: 10.1016/j.jaut.2018.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
472 Montano-Loza AJ, Ronca V, Ebadi M, Hansen BE, Hirschfield G, Elwir S, Alsaed M, Milkiewicz P, Janik MK, Marschall HU, Burza MA, Efe C, Calışkan AR, Harputluoglu M, Kabaçam G, Terrabuio D, de Quadros Onofrio F, Selzner N, Bonder A, Parés A, Llovet L, Akyıldız M, Arikan C, Manns MP, Taubert R, Weber AL, Schiano TD, Haydel B, Czubkowski P, Socha P, Ołdak N, Akamatsu N, Tanaka A, Levy C, Martin EF, Goel A, Sedki M, Jankowska I, Ikegami T, Rodriguez M, Sterneck M, Weiler-Normann C, Schramm C, Donato MF, Lohse A, Andrade RJ, Patwardhan VR, van Hoek B, Biewenga M, Kremer AE, Ueda Y, Deneau M, Pedersen M, Mayo MJ, Floreani A, Burra P, Secchi MF, Beretta-Piccoli BT, Sciveres M, Maggiore G, Jafri SM, Debray D, Girard M, Lacaille F, Lytvyak E, Mason AL, Heneghan M, Oo YH; International Autoimmune Hepatitis Group (IAIHG). Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. J Hepatol 2022:S0168-8278(22)00067-8. [PMID: 35143897 DOI: 10.1016/j.jhep.2022.01.022] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
473 Cargill T, Culver EL. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Front Immunol 2021;12:661196. [PMID: 33936097 DOI: 10.3389/fimmu.2021.661196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Johanet C, Ballot E. Auto-antibodies in autoimmune hepatitis: Anti-smooth muscle antibodies (ASMA). Clinics and Research in Hepatology and Gastroenterology 2012;36:189-91. [DOI: 10.1016/j.clinre.2011.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
475 Kelly C, Zen Y, Heneghan MA. Post-Transplant Immunosuppression in Autoimmune Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.07.002] [Reference Citation Analysis]
476 Kim SK, Marusawa H, Eso Y, Nishikawa H, Ueda Y, Kita R, Kimura T, Chiba T, Osaki Y, Kudo M. Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study. Digestion. 2011;84 Suppl 1:43-49. [PMID: 22156485 DOI: 10.1159/000333212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
477 Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagström H, Purnak T, Muratori L, Werner M, Muratori P, Klintman D, Schiano TD, Montano-loza AJ, Berg T, Larsen FS, Alkhouri N, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. Dig Dis Sci 2018;63:1348-54. [DOI: 10.1007/s10620-018-5011-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
478 Czaja AJ. Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci 2013;58:897-914. [PMID: 23090425 DOI: 10.1007/s10620-012-2445-4] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 8.7] [Reference Citation Analysis]
479 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 155] [Article Influence: 66.0] [Reference Citation Analysis]
480 Sorin B, Pineton de Chambrun M, Haroche J, Freund Y, Miyara M, Charlotte F, Lebrun-Vignes B, Amoura Z, Cohen Aubart F. [Autoimmune hepatitis triggered by nitrofurantoin: A rare drug-induced toxicity]. Rev Med Interne 2016;37:131-4. [PMID: 26404522 DOI: 10.1016/j.revmed.2015.07.003] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
481 Khairy M, El-Raziky M, El-Akel W, Abdelbary MS, Khatab H, El-Kholy B, Esmat G, Mabrouk M. Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response. Liver Int. 2013;33:1504-1509. [PMID: 23763380 DOI: 10.1111/liv.12227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
482 Della Corte C, Sartorelli MR, Sindoni CD, Girolami E, Giovannelli L, Comparcola D, Nobili V. Autoimmune hepatitis in children: an overview of the disease focusing on current therapies. European Journal of Gastroenterology & Hepatology 2012;24:739-46. [DOI: 10.1097/meg.0b013e328353750c] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
483 Moy L, Levine J. Autoimmune hepatitis: a classic autoimmune liver disease. Curr Probl Pediatr Adolesc Health Care. 2014;44:341-346. [PMID: 25466500 DOI: 10.1016/j.cppeds.2014.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
484 Klein R. Evidence for immunological (allergic) mechanisms in a subgroup of patients with phenprocoumon-induced liver disease. Eur J Clin Pharmacol 2009;65:1195-201. [DOI: 10.1007/s00228-009-0705-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
485 Johanet C, Ballot E. Auto-antibodies in autoimmune hepatitis: anti-soluble liver antigen (SLA). Clin Res Hepatol Gastroenterol. 2012;36:244-246. [PMID: 22306052 DOI: 10.1016/j.clinre.2011.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
486 Czaja AJ. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol. 2013;7:365-385. [PMID: 23639095 DOI: 10.1586/egh.13.21] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
487 Al-Shaebi F, Wenzhang L, Hezam K, Almezgagi M, Wei L. Recent insights of the role and signalling pathways of interleukin-34 in liver diseases. Int Immunopharmacol 2020;89:107023. [PMID: 33129098 DOI: 10.1016/j.intimp.2020.107023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
488 Zhu JY, Han Y. Autoimmune hepatitis: Unveiling faces. J Dig Dis 2015;16:483-8. [PMID: 26332151 DOI: 10.1111/1751-2980.12285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
489 Grønbaek L, Vilstrup H, Pedersen L, Jepsen P. Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study. Liver Int 2019;39:205-14. [PMID: 30218621 DOI: 10.1111/liv.13963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
490 Hashimoto Y, Miyaki D, Murakami E, Nagaoki Y, Kimura Y, Takahiro A, Katamura Y, Kawaoka T, Takaki S, Tsuge M, Hiraga N, Hiramatsu A, Waki K, Imamura M, Aikata H, Takahashi S, Arihiro K, Ohdan H, Chayama K. Multicentric hepatocarcinogenesis at 6 and 13 years after sustained viral response to hepatitis C virus. Clin J Gastroenterol 2012;5:204-9. [PMID: 26182322 DOI: 10.1007/s12328-012-0303-8] [Reference Citation Analysis]
491 Zeng J, Huang ZP, Zheng J, Wu T, Zheng RQ. Non-invasive assessment of liver fibrosis using two-dimensional shear wave elastography in patients with autoimmune liver diseases. World J Gastroenterol 2017; 23(26): 4839-4846 [PMID: 28765706 DOI: 10.3748/wjg.v23.i26.4839] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
492 Stephens C, Andrade RJ. Genetic Predisposition to Drug-Induced Liver Injury. Clin Liver Dis 2020;24:11-23. [PMID: 31753244 DOI: 10.1016/j.cld.2019.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
493 Oikonomou KG, Zachou K, Dalekos GN. Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun Rev. 2011;10:389-396. [PMID: 21241830 DOI: 10.1016/j.autrev.2010.12.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
494 Wang QX, Jiang WJ, Miao Q, Xiao X, Zhang HY, Huang SS, Shen L, Hua J, Li H, Li S. Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience. J Dig Dis. 2013;14:175-180. [PMID: 23216916 DOI: 10.1111/1751-2980.12022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
495 Weiler-normann C, Lohse AW. Acute autoimmune hepatitis: Many open questions. Journal of Hepatology 2014;61:727-9. [DOI: 10.1016/j.jhep.2014.06.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
496 Sood V, Lal BB, Rawat D, Khanna R, Rastogi A, Bihari C, Kumar G, Alam S. Spectrum of Pediatric Autoimmune Liver Disease and Validation of Its Diagnostic Scores in Indian Children. J Pediatr Gastroenterol Nutr 2018;67:e65-72. [PMID: 29901555 DOI: 10.1097/MPG.0000000000002050] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
497 Beisel C, Weiler-Normann C, Teufel A, Lohse AW. Association of autoimmune hepatitis and systemic lupus erythematodes: A case series and review of the literature. World J Gastroenterol 2014; 20(35): 12662-12667 [PMID: 25253972 DOI: 10.3748/wjg.v20.i35.12662] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
498 Jegadeesan R, Navaneethan U, Bharadwaj S, Hammel J, Sanaka MR, Shen B. Impact of Concurrent Non-IBD Immunological Diseases on the Outcome of Primary Sclerosing Cholangitis: . Inflammatory Bowel Diseases 2016;22:948-54. [DOI: 10.1097/mib.0000000000000690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
499 Wu R, Liu Y, Yan R, Liu X, Duan L. Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis. J Transl Med 2020;18:384. [PMID: 33036620 DOI: 10.1186/s12967-020-02556-w] [Reference Citation Analysis]
500 Efe C. Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship? Autoimmun Rev. 2013;12:337-339. [PMID: 22841985 DOI: 10.1016/j.autrev.2012.03.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
501 Efe C, Kav T, Aydin C, Cengiz M, Imga NN, Purnak T, Smyk DS, Torgutalp M, Turhan T, Ozenirler S, Ozaslan E, Bogdanos DP. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci. 2014;59:3035-3042. [PMID: 25002309 DOI: 10.1007/s10620-014-3267-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
502 Kaur N, Minz RW, Anand S, Saikia B, Aggarwal R, Das A, Thapa BR, Chawla YK. HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population. J Clin Exp Hepatol 2014;4:14-8. [PMID: 25755530 DOI: 10.1016/j.jceh.2013.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
503 Kuhn T, Sayegh P, Jones JD, Smith J, Sarma MK, Ragin A, Singer EJ, Albert Thomas M, Thames AD, Castellon SA, Hinkin CH. Improvements in brain and behavior following eradication of hepatitis C. J Neurovirol. 2017;23:593-602. [PMID: 28560632 DOI: 10.1007/s13365-017-0533-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
504 Liberal R, Mieli-vergani G, Vergani D. Autoimmune hepatitis: From mechanisms to therapy. Revista Clínica Española (English Edition) 2016;216:372-83. [DOI: 10.1016/j.rceng.2016.04.004] [Reference Citation Analysis]
505 Marí-Alfonso B, Simeón-Aznar CP, Guillén-Del Castillo A, Rubio-Rivas M, Trapiella-Martínez L, Todolí-Parra JA, Rodríguez Carballeira M, Marín-Ballvé A, Iniesta-Arandia N, Colunga-Argüelles D, Castillo-Palma MJ, Sáez-Comet L, Egurbide-Arberas MV, Ortego-Centeno N, Freire M, Vargas Hitos JA, Chamorro AJ, Madroñero-Vuelta AB, Perales-Fraile I, Pla-Salas X, Fernández-De-La-Puebla RA, Fonollosa-Pla V, Tolosa-Vilella C; RESCLE Investigators., Systemic Autoimmune Diseases Study Group (GEAS). Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry. Semin Arthritis Rheum 2018;47:849-57. [PMID: 29246416 DOI: 10.1016/j.semarthrit.2017.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
506 Valgeirsson KB, Hreinsson JP, Björnsson ES. Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver Int 2019;39:2341-9. [PMID: 31436903 DOI: 10.1111/liv.14224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
507 Heijke R, Ahmad A, Frodlund M, Wirestam L, Dahlström Ö, Dahle C, Kechagias S, Sjöwall C. Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study. J Clin Med 2021;10:3820. [PMID: 34501268 DOI: 10.3390/jcm10173820] [Reference Citation Analysis]
508 Barrio J, Piqueras B, Rodrigo G, Rivero M. Epistaxis como forma de inicio de enfermedad hepática. Anales de Pediatría 2009;70:599-601. [DOI: 10.1016/j.anpedi.2009.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
509 Schulte-Frohlinde E. [Elevated liver enzymes--what to do and when]. MMW Fortschr Med 2012;154:65-9; quiz 70. [PMID: 23270060 DOI: 10.1007/s15006-012-1603-0] [Reference Citation Analysis]
510 Matsumoto K, Kikuchi K, Kajiyama Y, Takano Y, Mabuchi M, Doi S, Sato K, Miyakawa H, Yasuda I. Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection. Intern Med 2018;57:2669-73. [PMID: 29709942 DOI: 10.2169/internalmedicine.0613-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
511 Gao R, Gao F, Li G, Hao JY. Health-related quality of life in chinese patients with chronic liver disease. Gastroenterol Res Pract. 2012;2012:516140. [PMID: 22701477 DOI: 10.1155/2012/516140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
512 Muratori P, Granito A, Quarneti C, Ferri S, Menichella R, Cassani F, Pappas G, Bianchi FB, Lenzi M, Muratori L. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol. 2009;50:1210-1218. [PMID: 19395113 DOI: 10.1016/j.jhep.2009.01.020] [Cited by in Crossref: 84] [Cited by in F6Publishing: 74] [Article Influence: 6.5] [Reference Citation Analysis]
513 Jo W, Suh YS, Lee SI, Cheon YH, Hong J, Lee SS, Kim JE, Ko GH, Kim HO. Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy. Clin Mol Hepatol 2017;23:184-7. [PMID: 28479589 DOI: 10.3350/cmh.2016.0035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
514 Vieira CL, Baldaia C, Fatela N, Ramalho F, Cardoso C. Case of acute hepatitis E with concomitant signs of autoimmunity. World J Hepatol 2013; 5(3): 152-155 [PMID: 23556050 DOI: 10.4254/wjh.v5.i3.152] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
515 Ozaslan E, Efe C, Heurgué-Berlot A, Kav T, Masi C, Purnak T, Muratori L, Ustündag Y, Bresson-Hadni S, Thiéfin G. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2014;12:863-869. [PMID: 24076417 DOI: 10.1016/j.cgh.2013.09.021] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
516 Ebadi M, Bhanji RA, Mazurak VC, Lytvyak E, Mason A, Czaja AJ, Montano-loza AJ. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Aliment Pharmacol Ther 2019;49:173-82. [DOI: 10.1111/apt.15029] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
517 Gordon V, Adhikary R, Appleby V, Das D, Day J, Delahooke T, Dixon S, Elphick D, Hardie C, Hoeroldt B, Hooper P, Hutchinson J, Jones R, Khan F, Aithal GP, Mcgonigle J, Nelson A, Nkhoma A, Pelitari S, Prince M, Prosser A, Sathanarayana V, Savva S, Shah N, Saksena S, Thayalasekaran S, Vani D, Yeoman A, Gleeson D; The UK Multi‐Centre AIH Audit Group. Diagnosis, presentation and initial severity of Autoimmune Hepatitis ( AIH ) in patients attending 28 hospitals in the UK. Liver Int 2018;38:1686-95. [DOI: 10.1111/liv.13724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
518 Guedes ALV, Andrade AR, Nunes VS, Lima FR, de Mello ES, Ono SK, Terrabuio DRB, Cançado ELR. Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction. Autops Case Rep 2017;7:35-42. [PMID: 28740837 DOI: 10.4322/acr.2017.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
519 Pniewska A, Sobolewska-Pilarczyk M, Pawłowska M. Evaluation of the effectiveness of treatment with prednisone and azathioprine of autoimmune hepatitis in children. Prz Gastroenterol 2016;11:18-23. [PMID: 27110306 DOI: 10.5114/pg.2015.52566] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
520 Seo KI, Kang SB. [Hepatobiliary Manifestation of Inflammatory Bowel Disease]. Korean J Gastroenterol 2019;73:248-59. [PMID: 31132831 DOI: 10.4166/kjg.2019.73.5.248] [Reference Citation Analysis]
521 Pakchotanon R, Ye JY, Cook RJ, Chandran V, Gladman DD. Liver Abnormalities in Patients with Psoriatic Arthritis. J Rheumatol 2020;47:847-53. [PMID: 31615918 DOI: 10.3899/jrheum.181312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
522 Pérez Martínez J, Castro Márquez C, Pereira Gallardo S, Jiménez Sáenz M, Herrerías Gutiérrez JM. Porfiria aguda intermitente subclínica. Etiología inusual de hepatitis crónica. Gastroenterología y Hepatología 2011;34:262-5. [DOI: 10.1016/j.gastrohep.2011.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
523 Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis. Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan. Hepatol Res 2014;44 Suppl S1:71-90. [PMID: 24397841 DOI: 10.1111/hepr.12270] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
524 Bolia R, Srivastava A, Yachha SK, Poddar U. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease. Journal of Hepatology 2018;68:449-55. [DOI: 10.1016/j.jhep.2017.10.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
525 Kurihara S, Kimura T, Tanaka N, Yanagisawa T, Kobayashi H, Kanai K, Umemura T, Kobayashi M, Mori H, Wada S. Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease. Clin J Gastroenterol 2020;13:434-42. [PMID: 31745825 DOI: 10.1007/s12328-019-01059-6] [Reference Citation Analysis]
526 Vergani D, Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother. 2011;12:607-613. [PMID: 21235284 DOI: 10.1517/14656566.2011.524206] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
527 Tagawa Y, Saito T, Takada K, Kawahata K, Kohsaka H. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil. Lupus 2016;25:543-6. [DOI: 10.1177/0961203315625118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
528 Liang JB, Chen Y, Chen RL, Li YK, Li B, You ZR, Li Y, Zhang J, Huang BY, Wei YR, Lyu ZW, Lian M, Xiao X, Wang QX, Tang RQ, Fang JY, Chen XY, Ma X, Miao Q. CD8+ T cells actively penetrate hepatocytes via the CD44/p-ERM/F-actin pathway in autoimmune hepatitis. J Dig Dis 2021;22:351-62. [PMID: 33928766 DOI: 10.1111/1751-2980.12995] [Reference Citation Analysis]
529 Gupta T, Dhiman RK, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla Y. Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 2017;7:9-15. [PMID: 28348465 DOI: 10.1016/j.jceh.2016.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
530 Hiejima E, Komatsu H, Sogo T, Inui A, Fujisawa T. Utility of simplified criteria for the diagnosis of autoimmune hepatitis in children. J Pediatr Gastroenterol Nutr. 2011;52:470-473. [PMID: 21407112 DOI: 10.1097/mpg.0b013e3181fc1e0b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 8] [Article Influence: 3.1] [Reference Citation Analysis]
531 Stirnimann G, Ebadi M, Czaja AJ, Montano‐loza AJ. Recurrent and De Novo Autoimmune Hepatitis. Liver Transpl 2019;25:152-66. [DOI: 10.1002/lt.25375] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 9.7] [Reference Citation Analysis]
532 Corrigan M, Hirschfield GM, Oo YH, Adams DH. Autoimmune hepatitis: an approach to disease understanding and management. Br Med Bull 2015;114:181-91. [DOI: 10.1093/bmb/ldv021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
533 Abe K, Takahashi A, Nozawa Y, Imaizumi H, Hayashi M, Okai K, Kanno Y, Watanabe H, Ohira H. The utility of IgG, IgM, and CD138 immunohistochemistry in the evaluation of autoimmune liver diseases. Med Mol Morphol. 2014;47:162-168. [PMID: 24969678 DOI: 10.1007/s00795-014-0082-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
534 Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol. 2009;25:215-222. [PMID: 19387256 DOI: 10.1097/mog.0b013e328324ed06] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
535 Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance. Front Immunol. 2018;9:609. [PMID: 29636752 DOI: 10.3389/fimmu.2018.00609] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
536 Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, Lucena MI, Castiella A, Lindor K, Björnsson E. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011;54:931-9. [PMID: 21674554 DOI: 10.1002/hep.24481] [Cited by in Crossref: 211] [Cited by in F6Publishing: 174] [Article Influence: 19.2] [Reference Citation Analysis]
537 Zhang H, Lian M, Zhang J, Bian Z, Tang R, Miao Q, Peng Y, Fang J, You Z, Invernizzi P, Wang Q, Gershwin ME, Ma X. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation. Hepatology 2018;67:232-46. [PMID: 28777871 DOI: 10.1002/hep.29418] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
538 Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol. 2011;55:747-749. [PMID: 21396413 DOI: 10.1016/j.jhep.2011.02.024] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
539 Zhou SF, Liu SY, Jia YH. Autoimmune hepatitis: an analysis of 46 cases. Shijie Huaren Xiaohua Zazhi 2010; 18(24): 2608-2613 [DOI: 10.11569/wcjd.v18.i24.2608] [Reference Citation Analysis]
540 Podgórska J, Werel P, Klapaczyński J, Orzechowska D, Wudarski M, Gietka A. Liver involvement in rheumatic diseases. Reumatologia 2020;58:289-96. [PMID: 33227094 DOI: 10.5114/reum.2020.99782] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
541 Zingaretti C, Arigò M, Cardaci A, Moro M, Crosti M, Sinisi A, Sugliano E, Cheroni C, Marabita F, Nogarotto R. Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteomics. 2012;11:1885-1897. [PMID: 22997428 DOI: 10.1074/mcp.m112.018713] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
542 Kerkar N. Pediatric Autoimmune Hepatitis: What Do You Do When First-line Therapy Fails? J Pediatr Gastroenterol Nutr 2017;65:2-4. [PMID: 28644341 DOI: 10.1097/MPG.0000000000001621] [Reference Citation Analysis]
543 Theocharidou E, Heneghan MA. Current and future perspectives in autoimmune hepatitis. Br J Hosp Med (Lond) 2018;79:151-9. [PMID: 29528732 DOI: 10.12968/hmed.2018.79.3.151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
544 Reshetnyak VI. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol 2015; 21(25): 7683-7708 [PMID: 26167070 DOI: 10.3748/wjg.v21.i25.7683] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
545 Kriese S, Heneghan MA. Current concepts in the diagnosis and management of autoimmune hepatitis. Frontline Gastroenterol 2013;4:2-11. [PMID: 28839695 DOI: 10.1136/flgastro-2012-100208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
546 Di Giorgio A, Bartolini E, Calvo PL, Cananzi M, Cirillo F, Della Corte C, Dionisi-Vici C, Indolfi G, Iorio R, Maggiore G, Mandato C, Nebbia G, Nicastro E, Pinon M, Ranucci G, Sciveres M, Vajro P, D'Antiga L. Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group. Dig Liver Dis 2021;53:545-57. [PMID: 33775575 DOI: 10.1016/j.dld.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
547 Eugène C. Comment on the British Society of Gastroenterology guidelines for management of autoimmune hepatitis (part 1). Clin Res Hepatol Gastroenterol 2012;36:408-11. [PMID: 22634113 DOI: 10.1016/j.clinre.2012.04.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
548 Liukkonen V, Nordin A, Arola J, Färkkilä M, Åberg F. Role of Autoimmunity in Patients Transplanted for Acute Liver Failure of Unknown Origin: A Clinical and Graft Biopsy Analysis. Liver Transpl 2020;26:764-73. [PMID: 32034878 DOI: 10.1002/lt.25729] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
549 Wilde AB, Lieb C, Leicht E, Greverath LM, Steinhagen LM, Wald de Chamorro N, Petersen J, Hofmann WP, Hinrichsen H, Heyne R, Berg T, Naumann U, Schwenzer J, Vermehren J, Geier A, Tacke F, Müller T. Real-World Clinical Management of Patients with Primary Biliary Cholangitis-A Retrospective Multicenter Study from Germany. J Clin Med 2021;10:1061. [PMID: 33806503 DOI: 10.3390/jcm10051061] [Reference Citation Analysis]
550 Zhu Z, Cao HL, Zhu HH, Xu YJ, Yin J. Lipid-lowering agents-induced autoimmune hepatitis: A systematic review. Shijie Huaren Xiaohua Zazhi 2015; 23(13): 2130-2134 [DOI: 10.11569/wcjd.v23.i13.2130] [Reference Citation Analysis]
551 El-Shabrawi M, El-Karaksy H, Mohsen N, Isa M, Al-Biltagi M, El-Ansari M. Celiac disease in children and adolescents with autoimmune hepatitis: a single-centre experience. J Trop Pediatr 2011;57:104-8. [PMID: 20571152 DOI: 10.1093/tropej/fmq057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
552 Visseren T, Darwish Murad S. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation. Best Practice & Research Clinical Gastroenterology 2017;31:187-98. [DOI: 10.1016/j.bpg.2017.04.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
553 Muratori P, Lalanne C, Barbato E, Fabbri A, Cassani F, Lenzi M, Muratori L. Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy. Clin Gastroenterol Hepatol. 2016;14:139-146. [PMID: 26192146 DOI: 10.1016/j.cgh.2015.07.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
554 De Luca-Johnson J, Wangensteen KJ, Hanson J, Krawitt E, Wilcox R. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2016;61:2710-20. [PMID: 27262844 DOI: 10.1007/s10620-016-4213-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
555 Tajiri K, Shimizu Y, Tokimitsu Y, Tsuneyama K, Sugiyama T. An elderly man with syncytial giant cell hepatitis successfully treated by immunosuppressants. Intern Med 2012;51:2141-4. [PMID: 22892492 DOI: 10.2169/internalmedicine.51.7870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
556 Poizot-Martin I, Rosenthal E, Gilbert C, Cano CE, Simon A, Lascoux-Combe C, Alric L, Gervais A, Neau D, Esterle L, Salmon D, Sogni P, Wittkop L; ANRS CO13 HEPAVIH Study Group. Nadir CD4 Is Negatively Associated With Antinuclear Antibody Detection in HCV/HIV-Coinfected Patients. J Acquir Immune Defic Syndr 2019;80:461-6. [PMID: 30570526 DOI: 10.1097/QAI.0000000000001940] [Reference Citation Analysis]
557 Efe C, Hagström H, Ytting H, Bhanji RA, Müller NF, Wang Q, Purnak T, Muratori L, Werner M, Marschall HU, Muratori P, Gunşar F, Klintman D, Parés A, Heurgué-Berlot A, Schiano TD, Cengiz M, May-Sien Tana M, Ma X, Montano-Loza AJ, Berg T, Verma S, Larsen FS, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. Clin Gastroenterol Hepatol 2017;15:1950-1956.e1. [PMID: 28603052 DOI: 10.1016/j.cgh.2017.06.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 11.2] [Reference Citation Analysis]
558 Freire A, Levy C. Ethnic and Racial Differences in Autoimmune Liver Diseases. Curr Hepatology Rep 2018;17:135-42. [DOI: 10.1007/s11901-018-0399-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
559 Eder M, Strassl R, Beinhardt S, Stättermayer AF, Kozbial K, Lagler H, Holzmann H, Trauner M, Hofer H. High seroprevalence of anti-Hepatitis E antibodies in Austrian patients with autoimmune hepatitis. Liver Int 2019;39:640-5. [PMID: 30431228 DOI: 10.1111/liv.14005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
560 Arcos-Machancoses JV, Molera Busoms C, Julio Tatis E, Victoria Bovo M, Quintero Bernabeu J, Juampérez Goñi J, Crujeiras Martínez V, Martin de Carpi J. Accuracy of the 2008 Simplified Criteria for the Diagnosis of Autoimmune Hepatitis in Children. Pediatr Gastroenterol Hepatol Nutr 2018;21:118-26. [PMID: 29713609 DOI: 10.5223/pghn.2018.21.2.118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
561 Kapila N, Higa JT, Longhi MS, Robson SC. Autoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of Disease. J Clin Transl Hepatol 2013;1:79-86. [PMID: 26356124 DOI: 10.14218/JCTH.2013.00015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
562 Trivedi PJ, Chapman RW. PSC, AIH and overlap syndrome in inflammatory bowel disease. Clin Res Hepatol Gastroenterol. 2012;36:420-436. [PMID: 22306055 DOI: 10.1016/j.clinre.2011.10.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
563 Tozzoli R, Villalta D, Bizzaro N. Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review. Clin Rev Allergy Immunol 2017;53:68-77. [PMID: 27498835 DOI: 10.1007/s12016-016-8579-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
564 Hartl J, Ehlken H, Weiler-Normann C, Sebode M, Kreuels B, Pannicke N, Zenouzi R, Glaubke C, Lohse AW, Schramm C. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis. J Hepatol. 2015;62:642-646. [PMID: 25457202 DOI: 10.1016/j.jhep.2014.10.018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
565 Kimura N, Yamagiwa S, Sugano T, Horigome R, Setsu T, Tominaga K, Kamimura H, Takamura M, Terai S. Usefulness of chemokine C-C receptor 7- /programmed cell death-1+ follicular helper T cell subset frequencies in the diagnosis of autoimmune hepatitis. Hepatol Res 2019;49:1026-33. [PMID: 31020718 DOI: 10.1111/hepr.13356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
566 Simoes CC, Saldarriaga OA, Utay NS, Stueck AE, Merwat SK, Merwat SN, Schiano TD, Fiel MI, Stevenson HL. Direct-Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis. Hepatol Commun 2019;3:1113-23. [PMID: 31388631 DOI: 10.1002/hep4.1388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
567 Kerkar N, Chan A. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome. Clinics in Liver Disease 2018;22:689-702. [DOI: 10.1016/j.cld.2018.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
568 Meunier L, Ursic-Bedoya J, Pageaux GP, Larrey D. Pantoprazole-induced autoimmune chronic hepatitis. Liver Int 2018;38:995-9. [PMID: 29532602 DOI: 10.1111/liv.13737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
569 Wat H, Haber RM. Trends in the Association between Pyoderma Gangrenosum and Autoimmune Hepatitis: Case Report and Review of the Literature. J Cutan Med Surg 2014;18:345-52. [DOI: 10.2310/7750.2013.13177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
570 Fabbri A, Lenzi M. Non-invasive markers of inflammation in autoimmune hepatitis. Liver Int. 2013;33:1295-1297. [PMID: 24011359 DOI: 10.1111/liv.12251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
571 Ganger DR, Rule J, Rakela J, Bass N, Reuben A, Stravitz RT, Sussman N, Larson AM, James L, Chiu C, Lee WM; Acute Liver Failure Study Group. Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality. Am J Gastroenterol 2018;113:1319. [PMID: 29946176 DOI: 10.1038/s41395-018-0160-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
572 Efe C, Ozaslan E, Wahlin S, Purnak T, Muratori L, Quarneti C, Yüksel O, Muratori P. Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study. Liver Int 2013;33:190-6. [DOI: 10.1111/liv.12022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
573 Dong H, Slain D, Cheng J, Ma W, Liang W. Eighteen cases of liver injury following ingestion of Polygonum multiflorum. Complement Ther Med. 2014;22:70-74. [PMID: 24559819 DOI: 10.1016/j.ctim.2013.12.008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
574 Chapin CA, Burn T, Meijome T, Loomes KM, Melin-Aldana H, Kreiger PA, Whitington PF, Behrens EM, Alonso EM. Indeterminate pediatric acute liver failure is uniquely characterized by a CD103+ CD8+ T-cell infiltrate. Hepatology 2018;68:1087-100. [PMID: 29603342 DOI: 10.1002/hep.29901] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
575 Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013;382:1433-1444. [PMID: 23768844 DOI: 10.1016/s0140-6736(12)62163-1] [Cited by in Crossref: 143] [Cited by in F6Publishing: 65] [Article Influence: 15.9] [Reference Citation Analysis]
576 Lleo A, Bian Z, Zhang H, Miao Q, Yang F, Peng Y, Chen X, Tang R, Wang Q, Qiu D, Fang J, Sobacchi C, Villa A, Di Tommaso L, Roncalli M, Gershwin ME, Ma X, Invernizzi P. Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis. PLoS One 2016;11:e0159612. [PMID: 27631617 DOI: 10.1371/journal.pone.0159612] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
577 Johanet C, Beleoken E, Ballot E. Autoantibodies in autoimmune hepatitis: antinuclear antibodies (ANA). Clin Res Hepatol Gastroenterol. 2012;36:394-396. [PMID: 22481089 DOI: 10.1016/j.clinre.2012.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
578 Efe C, Ozaslan E, Kav T, Purnak T, Shorbagi A, Ozkayar O, Berlot AH, Sökmensuer C, Muratori P. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. Autoimmun Rev. 2012;11:330-334. [PMID: 22001521 DOI: 10.1016/j.autrev.2011.09.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
579 Behairy BES, Sira MM, Zalata KR, Salama ESE, Abd-Allah MA. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? World J Gastroenterol 2016; 22(16): 4238-4249 [PMID: 27122674 DOI: 10.3748/wjg.v22.i16.4238] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
580 Montano-Loza AJ, Bhanji RA, Wasilenko S, Mason AL. Systematic review: recurrent autoimmune liver diseases after liver transplantation. Aliment Pharmacol Ther. 2017;45:485-500. [PMID: 27957759 DOI: 10.1111/apt.13894] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 11.7] [Reference Citation Analysis]
581 Nares-cisneros J, Jaramillo-rodríguez Y. Hepatitis autoinmune en niños: evolución de 20 casos del norte de México. Revista de Gastroenterología de México 2014;79:238-43. [DOI: 10.1016/j.rgmx.2014.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
582 El Shazly RI, Mohammed WHS, Mohamed SF, Elnasr MIS. Prevalence and risk factors of liver biochemical abnormalities in patients with systemic lupus erythematosus. Egypt Rheumatol Rehabil 2014;41:139-47. [DOI: 10.4103/1110-161x.147352] [Reference Citation Analysis]
583 Fujiwara K, Seza K, Fukuda Y, Nakano M, Yokosuka O. A case of primary biliary cirrhosis and autoimmune hepatitis overlap showing acute presentation and transient seropositivity for immunoglobulin G and anti-nuclear antibody. Clin J Gastroenterol 2013;6:465-9. [PMID: 26182138 DOI: 10.1007/s12328-013-0423-9] [Reference Citation Analysis]
584 Miyata H, Miyata S. Speculation of the Time-Dependent Change of FIB4 Index in Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Study. Can J Gastroenterol Hepatol 2018;2018:5323061. [PMID: 29721486 DOI: 10.1155/2018/5323061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
585 Rigopoulou EI, Dalekos GN. Can mathematical models be useful in clinical hepatology? Liver Int 2010;30:637-8. [PMID: 20331504 DOI: 10.1111/j.1478-3231.2010.02216.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
586 Mroskowiak A, Suleja A, Stec M, Kuczmik W, Migacz M, Holecki M. Autoimmune Hepatitis—Challenging Diagnosis. Medicina 2022;58:896. [DOI: 10.3390/medicina58070896] [Reference Citation Analysis]
587 Díaz-Ramírez GS, Marín-Zuluaga JI, Donado-Gómez JH, Muñoz-Maya O, Santos-Sánchez Ó, Restrepo-Gutiérrez JC. Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study. Gastroenterol Hepatol 2018;41:87-96. [PMID: 29126693 DOI: 10.1016/j.gastrohep.2017.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
588 Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol 2010; 16(8): 934-947 [PMID: 20180231 DOI: 10.3748/wjg.v16.i8.934] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
589 Tanwar A, Gupta GK, Chauhan V, Sharma D, Jain MK, Bhardwaj H, Jhajharia A, Nijhawan S. Celiac Disease and Portal Hypertension: A Causal Association or Just a Coincidence? J Clin Exp Hepatol 2020;10:290-5. [PMID: 32655231 DOI: 10.1016/j.jceh.2019.11.005] [Reference Citation Analysis]
590 Hippchen T, Sauer P, Göppert B, Schirmacher P, Gotthardt DN, Weiss KH, Stremmel W, Rupp C. Association between serum IgG level and clinical course in primary sclerosing cholangitis. BMC Gastroenterol 2019;19:153. [PMID: 31455255 DOI: 10.1186/s12876-019-1075-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
591 Righi S, Fiorini E, De Molo C, Cipriano V, Cassani F, Muratori L, Lenzi M, Morselli Labate AM, Serra C. ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study. J Ultrasound. 2012;15:226-231. [PMID: 23730386 DOI: 10.1016/j.jus.2012.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
592 Christen U, Hintermann E. Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough? Front Immunol 2022;13:898615. [DOI: 10.3389/fimmu.2022.898615] [Reference Citation Analysis]
593 Beleoken E, Leh H, Arnoux A, Ducot B, Nogues C, De Martin E, Johanet C, Samuel D, Mustafa MZ, Duclos-Vallée JC, Buckle M, Ballot E. SPRi-based strategy to identify specific biomarkers in systemic lupus erythematosus, rheumatoid arthritis and autoimmune hepatitis. PLoS One 2013;8:e84600. [PMID: 24376828 DOI: 10.1371/journal.pone.0084600] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
594 Castellanos Fernández MI, Cepeda Mullo ME, la Rosa Hernández D, Vega Sánchez H, González Fabian L, Gish RG, Torres González AL, Dorta Guridi Z. Autoimmune Hepatitis in Cuban Patients: A Retrospective Analysis of Clinical and Histological Profiles, Treatments, and Outcomes. Curr Ther Res Clin Exp 2020;93:100594. [PMID: 32922567 DOI: 10.1016/j.curtheres.2020.100594] [Reference Citation Analysis]
595 Kobayashi M, Kakuda Y, Harada K, Sato Y, Sasaki M, Ikeda H, Terada M, Mukai M, Kaneko S, Nakanuma Y. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis. World J Gastroenterol 2014; 20(13): 3597-3608 [PMID: 24707143 DOI: 10.3748/wjg.v20.i13.3597] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
596 Loddo I, Romano C, Cutrupi MC, Sciveres M, Riva S, Salpietro A, Ferraù V, Gallizzi R, Briuglia S. Autoimmune liver disease in Noonan Syndrome. European Journal of Medical Genetics 2015;58:188-90. [DOI: 10.1016/j.ejmg.2014.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
597 Mackay IR. Autoimmune Hepatitis: From the Clinic to the Diagnostics Laboratory. Lab Med 2011;42:224-33. [DOI: 10.1309/lm7eubrruplf9v6r] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
598 Aljumah AA, Al Jarallah B, Albenmousa A, Al Khathlan A, Al Zanbagi A, Al Quaiz M, Al-Judaibi B, Nabrawi K, Al Hamoudi W, Alghamdi M, Fallatah H. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi J Gastroenterol 2018;24:S1-S20. [PMID: 30264737 DOI: 10.4103/sjg.SJG_159_18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
599 Sharma S, Lal SB, Sachdeva M, Bhatia A, Varma N. Role of Granulocyte Colony Stimulating Factor on the Short-Term Outcome of Children with Acute on Chronic Liver Failure. J Clin Exp Hepatol 2020;10:201-10. [PMID: 32405176 DOI: 10.1016/j.jceh.2019.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
600 Kapila N, Ma Q, King LY. It Ain't Over Till It's Over. Clin Liver Dis (Hoboken) 2020;16:33-7. [PMID: 32922746 DOI: 10.1002/cld.961] [Reference Citation Analysis]
601 Acharya GK, Liao HI, Frunza-Stefan S, Patel R, Khaing M. Autoimmune Hepatitis: Diagnostic Dilemma When It Is Disguised as Iron Overload Syndrome. J Clin Exp Hepatol 2017;7:269-73. [PMID: 28970716 DOI: 10.1016/j.jceh.2017.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
602 Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity 2018;51:258-64. [PMID: 29890851 DOI: 10.1080/08916934.2018.1482884] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
603 Guzman G, Kallwitz ER, Wojewoda C, Chennuri R, Berkes J, Layden TJ, Cotler SJ. Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh. Case Rep Med. 2009;2009:918156. [PMID: 20130783 DOI: 10.1155/2009/918156] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
604 Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF AUTOIMMUNE HEPATITIS. Clin Res Hepatol Gastroenterol 2021;:101772. [PMID: 34332126 DOI: 10.1016/j.clinre.2021.101772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
605 You Z, Li Y, Wang Q, Zhao Z, Li Y, Qian Q, Li B, Zhang J, Huang B, Liang J, Chen R, Lyu Z, Chen Y, Lian M, Xiao X, Miao Q, Fang J, Lian Z, Eric Gershwin M, Tang R, Ma X. The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis. Hepatology 2021;74:847-63. [PMID: 33554350 DOI: 10.1002/hep.31739] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
606 Li Y, Li B, You Z, Zhang J, Wei Y, Li Y, Chen Y, Huang B, Wang Q, Miao Q, Peng Y, Fang J, Gershwin ME, Tang R, Greenberg SA, Ma X. Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis. Journal of Autoimmunity 2019;103:102293. [DOI: 10.1016/j.jaut.2019.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
607 Dyson JK, Wong LL, Bigirumurame T, Hirschfield GM, Kendrick S, Oo YH, Lohse AW, Heneghan MA, Jones DEJ; UK-AIH Consortium. Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom. Aliment Pharmacol Ther 2018;48:951-60. [PMID: 30226274 DOI: 10.1111/apt.14968] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
608 Chung SW, Lee J, Kim MA, Leem G, Kim SW, Chang Y, Lee HY, Yoon JS, Park JY, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon J. Additional fibrate treatment in UDCA‐refractory PBC patients. Liver Int 2019;39:1776-85. [DOI: 10.1111/liv.14165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
609 Renand A, Habes S, Mosnier JF, Aublé H, Judor JP, Vince N, Hulin P, Nedellec S, Métairie S, Archambeaud I, Brouard S, Gournay J, Conchon S. Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment. Hepatol Commun 2018;2:968-81. [PMID: 30094407 DOI: 10.1002/hep4.1202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
610 Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR; Practice Parameters Committee of the American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021;116:878-98. [PMID: 33929376 DOI: 10.14309/ajg.0000000000001259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
611 Arterbery AS, Yao J, Ling A, Avitzur Y, Martinez M, Lobritto S, Deng Y, Geliang G, Mehta S, Wang G, Knight J, Ekong UD. Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune Hepatitis. Front Immunol 2018;9:1612. [PMID: 30072988 DOI: 10.3389/fimmu.2018.01612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
612 Minz RW, Kaur N, Anand S, Aggarwal R, Saikia B, Das A, Chawla YK. Complete spectrum of AMA-M2 positive liver disease in north India. Hepatol Int 2012;6:790-5. [PMID: 26201527 DOI: 10.1007/s12072-011-9326-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
613 van Gerven NM, Verwer BJ, Witte BI, van Erpecum KJ, van Buuren HR, Maijers I, Visscher AP, Verschuren EC, van Hoek B, Coenraad MJ, Beuers UH, de Man RA, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Mulder CJ, van Nieuwkerk CM, Bouma G; Dutch Autoimmune hepatitis STUDY group. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014;49:1245-1254. [PMID: 25123213 DOI: 10.3109/00365521.2014.946083] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 12.0] [Reference Citation Analysis]
614 Varyani F, Card T, Kaye P, Aithal GP, West J. The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study. BMC Health Serv Res 2013;13:161. [PMID: 23635009 DOI: 10.1186/1472-6963-13-161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
615 Jiménez-Encarnación E, Ríos G, Muñoz-Mirabal A, Vilá LM. Euforia-induced acute hepatitis in a patient with scleroderma. BMJ Case Rep 2012;2012:bcr2012006907. [PMID: 23257938 DOI: 10.1136/bcr-2012-006907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
616 Björnsson ES. Primary sclerosing cholangitis: best practices for diagnosis. Expert Opinion on Orphan Drugs 2017;5:701-6. [DOI: 10.1080/21678707.2017.1358163] [Reference Citation Analysis]
617 Hisamochi A, Kage M, Ide T, Arinaga-Hino T, Amano K, Kuwahara R, Ogata K, Miyajima I, Kumashiro R, Sata M, Torimura T. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis. J Gastroenterol 2016;51:597-607. [PMID: 26519284 DOI: 10.1007/s00535-015-1131-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
618 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
619 Zhou Z, Lai P, Zhang S, Wang Y, Qu N, Lu D, Gao L, Xu L, Yang Y, Zhang T, Sun X, Zheng X, Liu Y, Liang H, Chen S. The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease. Biomed Res Int 2021;2021:6612477. [PMID: 33860040 DOI: 10.1155/2021/6612477] [Reference Citation Analysis]
620 Sawhney R, Dhingra S, Sood GK. Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave's Disease. Cureus 2019;11:e4598. [PMID: 31281763 DOI: 10.7759/cureus.4598] [Reference Citation Analysis]
621 Liaskos C, Mavropoulos A, Orfanidou T, Spyrou V, Athanasiou LV, Billinis C. The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis. Auto Immun Highlights 2012;3:87-93. [PMID: 26000131 DOI: 10.1007/s13317-012-0036-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
622 Lenti MV, Rossi CM, Melazzini F, Gastaldi M, Bugatti S, Rotondi M, Bianchi PI, Gentile A, Chiovato L, Montecucco C, Corazza GR, Di Sabatino A. Seronegative autoimmune diseases: A challenging diagnosis. Autoimmun Rev 2022;21:103143. [PMID: 35840037 DOI: 10.1016/j.autrev.2022.103143] [Reference Citation Analysis]
623 Pathak S, Kamat D. Autoimmune Hepatitis in Children. Pediatr Ann 2018;47:e81-6. [PMID: 29446799 DOI: 10.3928/19382359-20180126-01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
624 Miao Q, Bian Z, Tang R, Zhang H, Wang Q, Huang S, Xiao X, Shen L, Qiu D, Krawitt EL, Gershwin ME, Ma X. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 2015;48:226-35. [PMID: 25051956 DOI: 10.1007/s12016-014-8432-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
625 Efe C, Cengiz M, Kahramanoğlu-Aksoy E, Yilmaz B, Özşeker B, Beyazt Y, Tanoğlu A, Purnak T, Kav T, Turhan T, Ozenirler S, Ozaslan E, Wahlin S. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis. Eur J Gastroenterol Hepatol 2015;27:649-54. [PMID: 25860719 DOI: 10.1097/MEG.0000000000000355] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
626 Vierling JM. Diagnosis and treatment of autoimmune hepatitis. Curr Gastroenterol Rep. 2012;14:25-36. [PMID: 22179843 DOI: 10.1007/s11894-011-0236-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
627 Nunes MEG, Rosa DV, Fagundes EDT, Ferreira AR, Miranda DMD, Ferri Liu PM. HLA-DRB1 GENE POLYMORPHISMS IN PEDIATRIC PATIENTS WITH TYPE 1 AUTOIMMUNE HEPATITIS AND TYPE 1 AUTOIMMUNE HEPATITIS OVERLAP SYNDROME WITH AUTOIMMUNE CHOLANGITIS. Arq Gastroenterol 2019;56:146-50. [DOI: 10.1590/s0004-2803.201900000-29] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
628 Andrade RJ, Robles-diaz M, Castiella A. Characterizing Drug-Induced Liver Injury With Autoimmune Features. Clinical Gastroenterology and Hepatology 2016;14:1844-5. [DOI: 10.1016/j.cgh.2016.07.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
629 Moenne-loccoz R, Severac F, Baumert TF, Habersetzer F. Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis. Journal of Hepatology 2016;65:444-6. [DOI: 10.1016/j.jhep.2016.03.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
630 Mühling T, Rohrbach H, Schepp W, Gundling F. Overlap of concurrent extrahepatic autoimmune diseases is associated with milder disease severity of newly diagnosed autoimmune hepatitis. Hepatobiliary Pancreat Dis Int 2021;20:21-7. [PMID: 32830050 DOI: 10.1016/j.hbpd.2020.06.019] [Reference Citation Analysis]
631 Schotte H, Willeke P, Schmalhorst J, Schlüter B. Diagnostic Performance of an Anti-Actin Autoantibody Binding Enzyme Immunodot Blot in Autoimmune Hepatitis Type 1. J Clin Lab Anal 2016;30:123-9. [PMID: 25425293 DOI: 10.1002/jcla.21825] [Reference Citation Analysis]
632 Huang YQ. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World J Hepatol 2016; 8(33): 1419-1441 [PMID: 27957241 DOI: 10.4254/wjh.v8.i33.1419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
633 Chaouali M, Kochkar R, Messadi A, Tezeghdenti A, Azaiez MB, Abdallah HB, Yacoubi-oueslati B, Ghazouani E. Distribution of HLA-DRB1/DQB1 alleles and DRB1-DQB1 haplotypes among Tunisian patients with autoimmune hepatitis. Egyptian Journal of Medical Human Genetics 2017;18:335-9. [DOI: 10.1016/j.ejmhg.2017.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
634 Magalhães R, Fonseca M, Brandão I, Caridade S. Autoimmune hepatitis unmasked by nimesulide. BMJ Case Rep 2016;2016:bcr2015212884. [PMID: 26791119 DOI: 10.1136/bcr-2015-212884] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
635 Harada K. Histological Findings of Autoimmune Hepatitis. In: Ohira H, editor. Autoimmune Liver Diseases. Tokyo: Springer Japan; 2014. pp. 45-65. [DOI: 10.1007/978-4-431-54789-1_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
636 Puustinen L, Boyd S, Arkkila P, Isoniemi H, Arola J, Färkkilä M. Histologic surveillance after liver transplantation due to autoimmune hepatitis. Clin Transplant 2017;31:e12936. [DOI: 10.1111/ctr.12936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
637 Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G. Low Serum Hepcidin in Patients with Autoimmune Liver Diseases. PLoS One 2015;10:e0135486. [PMID: 26270641 DOI: 10.1371/journal.pone.0135486] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
638 Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, Gonzalez-Jimenez A, Yang Q, Gu J, Andrade RJ, Hoofnagle JH. A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology 2022. [PMID: 35014066 DOI: 10.1002/hep.32327] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
639 de Boer YS, van Nieuwkerk CM, Witte BI, Mulder CJ, Bouma G, Bloemena E. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology. 2015;66:351-362. [PMID: 25257662 DOI: 10.1111/his.12558] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
640 Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56:958-976. [PMID: 21327704 DOI: 10.1007/s10620-011-1611-4] [Cited by in Crossref: 170] [Cited by in F6Publishing: 134] [Article Influence: 15.5] [Reference Citation Analysis]
641 Sahebjam F, Vierling JM. Autoimmune hepatitis. Front Med 2015;9:187-219. [DOI: 10.1007/s11684-015-0386-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
642 Brahim I, Brahim I, Hazime R, Admou B. [Autoimmune hepatitis: Immunological diagnosis]. Presse Med 2017;46:1008-19. [PMID: 28919271 DOI: 10.1016/j.lpm.2017.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
643 Porta G, Carvalho ED, Santos JL, Gama J, Borges CV, Seixas RB, Ferreira AR, Miura IK, Silveira TR, Silva LR, Fagundes ED, Bellomo-brandao MA, Sawamura R, Vieira SM, Melere MU, Marques CD, Pugliese RP, Danesi VL, Porta A, Marsillac ME, Valladares MA, Menezes DG, Kieling C, Paula MND, Vasconcelos JR, Ferreira CT, Perin N, Resende LR, Maia J, Tommaso AMD, Hessel G. Autoimmune hepatitis in 828 Brazilian children and adolescents: clinical and laboratory findings, histological profile, treatments, and outcomes. Jornal de Pediatria 2019;95:419-27. [DOI: 10.1016/j.jped.2018.04.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
644 Rodés J. The road to developing clinical trials: the Barcelona Liver Unit's experience and the dedication to the dream. Hepatology 2013;57:857-66. [PMID: 22576440 DOI: 10.1002/hep.25833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
645 Mayo MJ. Management of autoimmune hepatitis. Curr Opin Gastroenterol. 2011;27:224-230. [PMID: 21451411 DOI: 10.1097/mog.0b013e3283457ce0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
646 Hiraide-Sasagawa A, Hiroishi K, Shimazaki T, Eguchi J, Ishii S, Morikawa K, Sakaki M, Doi H, Omori R, Kajiwara A, Hayashi E, Shiina M, Hirayama Y, Imawari M. Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis. Hepatol Res 2015;45:1152-4. [PMID: 25581267 DOI: 10.1111/hepr.12479] [Reference Citation Analysis]
647 Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y. Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis. Hepatol Res. 2009;39:241-246. [PMID: 19054143 DOI: 10.1111/j.1872-034x.2008.00454.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
648 Bogdanos DP, Gao B, Gershwin ME. Liver immunology. Compr Physiol. 2013;3:567-598. [PMID: 23720323 DOI: 10.1002/cphy.c120011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
649 Mendizabal M, Marciano S, Videla MG, Anders M, Zerega A, Balderramo DC, Tisi Baña MR, Barrabino M, Gil O, Mastai R, Yantorno S, Gadano A, Silva MO. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure. Eur J Gastroenterol Hepatol 2015;27:644-8. [PMID: 25923939 DOI: 10.1097/MEG.0000000000000353] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
650 Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis--Update 2015. J Hepatol. 2015;62:S100-S111. [PMID: 25920079 DOI: 10.1016/j.jhep.2015.03.005] [Cited by in Crossref: 164] [Cited by in F6Publishing: 138] [Article Influence: 27.3] [Reference Citation Analysis]
651 Calisti G, Irish DN, Ijaz S, Tedder RS, Moore K.  Acute hepatitis E mimicking a flare of disease in a patient with chronic autoimmune hepatitis. Ann Hepatol 2017;16:160-3. [PMID: 28051806 DOI: 10.5604/16652681.1226952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
652 Mendizabal M, Haddad L, Marciano S, Ganem FO, Paz S, Gruz F, Ridruejo E, Lurbet MF, Fernandez N, Descalzi V, Anders M, Gadano A, Martínez A, Silva YM. Hepatitis E infection is an infrequent cause of acute hepatitis in the metropolitan area of Buenos Aires. J Clin Virol 2020;126:104309. [PMID: 32155452 DOI: 10.1016/j.jcv.2020.104309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
653 Arvaniti P, Zachou K, Koukoulis GK, Dalekos GN. Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis. Case Reports Hepatol 2018;2018:9793868. [PMID: 29713554 DOI: 10.1155/2018/9793868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
654 Casal Moura M, Liberal R, Cardoso H, Horta e Vale AM, Macedo G. Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids. World J Hepatol 2014; 6(6): 410-418 [PMID: 25018851 DOI: 10.4254/wjh.v6.i6.410] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
655 Alsayed MAL, Elbeah SM, El-Desoky MM, Elziny SM, Megahed A. Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis. Pediatr Gastroenterol Hepatol Nutr 2020;23:63-71. [PMID: 31988876 DOI: 10.5223/pghn.2020.23.1.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
656 Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Drenth JPH, Heneghan MA. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months. Clin Gastroenterol Hepatol 2020;18:1609-1617.e4. [PMID: 31715274 DOI: 10.1016/j.cgh.2019.11.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
657 Liu XM, Xu Y, Bao J, Gao SJ, Hua J, Kang GL. Ursodeoxycholic acid combined with glucocorticoids for treatment of primary biliary cirrhosis with characteristics of autoimmune hepatitis. Shijie Huaren Xiaohua Zazhi 2017; 25(5): 456-462 [DOI: 10.11569/wcjd.v25.i5.456] [Reference Citation Analysis]
658 Dang LJ, Lubel JS, Gunatheesan S, Hosking P, Su J. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis. Australas J Dermatol. 2014;55:75-79. [PMID: 23651182 DOI: 10.1111/ajd.12054] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
659 Jeong SH. Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea. Clin Mol Hepatol 2018;24:10-9. [PMID: 29307132 DOI: 10.3350/cmh.2017.0066] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
660 Sherigar JM, Fazio R, Zuang M, Arsura E. Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease. Clin Pract 2012;2:e83. [PMID: 24765482 DOI: 10.4081/cp.2012.e83] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
661 Klein R, Hintz E, Staehler G. Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan. BMJ Case Rep. 2012;2012. [PMID: 22802555 DOI: 10.1136/bcr-01-2012-5494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
662 Gurung A, Assis DN, Mccarty TR, Mitchell KA, Boyer JL, Jain D. Histologic features of autoimmune hepatitis: a critical appraisal. Human Pathology 2018;82:51-60. [DOI: 10.1016/j.humpath.2018.07.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
663 Saadah OI, Bokhary RY. Anti-mitochondrial antibody positive autoimmune hepatitis triggered by EBV infection in a young girl. Arab Journal of Gastroenterology 2013;14:130-2. [DOI: 10.1016/j.ajg.2013.05.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
664 Sciveres M, Riva S, Campani D, Vitucci P, Gori L, Lopez N, Maggiore G. Visceral Leishmaniasis Mimicking Autoimmune Hepatitis. Journal of Pediatric Gastroenterology & Nutrition 2009;48:639-42. [DOI: 10.1097/mpg.0b013e31819a4e77] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
665 Lian M, Wang Q, Jiang X, Zhang J, Wei Y, Li Y, Li B, Chen W, Zhang H, Miao Q, Peng Y, Xiao X, Sheng L, Zhang W, Fang J, Tang R, Gershwin ME, Ma X. The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid-Derived Suppressor Cell Activation in Immunoglobulin G4-Related Sclerosing Cholangitis. Hepatology 2018;68:1922-36. [PMID: 29774578 DOI: 10.1002/hep.30095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
666 Alonso EM, Horslen SP, Behrens EM, Doo E. Pediatric acute liver failure of undetermined cause: A research workshop. Hepatology 2017;65:1026-37. [PMID: 27862115 DOI: 10.1002/hep.28944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
667 Terziroli Beretta-piccoli B, Mieli-vergani G, Vergani D. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity 2018;95:144-58. [DOI: 10.1016/j.jaut.2018.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
668 Dalekos GN, Koskinas J, Papatheodoridis GV. Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis. Ann Gastroenterol 2019;32:1-23. [PMID: 30598587 DOI: 10.20524/aog.2018.0330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
669 Saito M, Akutsu N, Numata Y, Ishigami K, Sasaki S, Nakase H. Development of anti-centromere antibody-positive autoimmune hepatitis after childbirth. Clin J Gastroenterol 2020;13:855-9. [DOI: 10.1007/s12328-020-01092-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
670 Grant CR, Holder BS, Liberal R, Heneghan MA, Ma Y, Mieli-Vergani G, Vergani D, Longhi MS. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. Clin Exp Immunol 2017;189:71-82. [PMID: 28257599 DOI: 10.1111/cei.12956] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
671 Shi J, Zhao J, Zhang X, Cheng Y, Hu J, Li Y, Zhao X, Shang Q, Sun Y, Tu B, Shi L, Gao B, Wang FS, Zhang Z. Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients. Sci Rep 2017;7:44544. [PMID: 28291251 DOI: 10.1038/srep44544] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
672 Beer A, Dienes HP. Autoimmune hepatitis-is histology conclusive? Ann Transl Med 2021;9:733. [PMID: 33987431 DOI: 10.21037/atm-20-5084] [Reference Citation Analysis]
673 Arcos-Machancoses JV, Molera Busoms C, Julio Tatis E, Bovo MV, Martín de Carpi J. Accuracy of the Simplified Criteria for Autoimmune Hepatitis in Children: Systematic Review and Decision Analysis. J Clin Exp Hepatol 2019;9:147-55. [PMID: 31024195 DOI: 10.1016/j.jceh.2018.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
674 Mendez-sanchez N, Arrese M, Gadano A, Oliveira CP, Fassio E, Arab JP, Chávez-tapia NC, Dirchwolf M, Torre A, Ridruejo E, Pinchemel-cotrim H, Castellanos Fernández MI, Uribe M, Girala M, Diaz-ferrer J, Restrepo JC, Padilla-machaca M, Dagher L, Gatica M, Olaechea B, Pessôa MG, Silva M. The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease. The Lancet Gastroenterology & Hepatology 2021;6:65-72. [DOI: 10.1016/s2468-1253(20)30340-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 62.0] [Reference Citation Analysis]
675 Efe C, Ozaslan E, Purnak T, Ozseker B, Kav T, Bayraktar Y. Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis. Clinics and Research in Hepatology and Gastroenterology 2012;36:185-8. [DOI: 10.1016/j.clinre.2011.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
676 Kanda T, Yasui S, Nakamura M, Nakamoto S, Takahashi K, Wu S, Sasaki R, Haga Y, Ogasawara S, Saito T, Kobayashi K, Kiyono S, Ooka Y, Suzuki E, Chiba T, Maruyama H, Imazeki F, Moriyama M, Kato N. Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis. Oncotarget. 2018;9:11631-11637. [PMID: 29545925 DOI: 10.18632/oncotarget.24391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
677 Martínez-casas OY, Díaz-ramírez GS, Marín-zuluaga JI, Muñoz-maya O, Santos O, Donado-gómez JH, Restrepo-gutiérrez JC. Differential characteristics in drug-induced autoimmune hepatitis: Drug-induced autoimmune hepatitis. JGH Open 2018;2:97-104. [DOI: 10.1002/jgh3.12054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
678 Hayashi M, Abe K, Fujita M, Takahashi A, Sekine H, Ohira H. Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100497] [Reference Citation Analysis]
679 Engel B, Laschtowitz A, Janik MK, Junge N, Baumann U, Milkiewicz P, Taubert R, Sebode M. Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. Eur J Med Genet 2021;64:104214. [PMID: 33812046 DOI: 10.1016/j.ejmg.2021.104214] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
680 Corpechot C, Chazouillères O. [Autoimmune hepatitis: diagnostic and therapeutic up-to-date]. Rev Med Interne 2010;31:606-14. [PMID: 20674103 DOI: 10.1016/j.revmed.2009.05.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
681 Xu Q, Sheng L, Bao H, Chen X, Guo C, Li H, Ma X, Qiu D, Hua J. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2017;32:639-644. [PMID: 27505153 DOI: 10.1111/jgh.13508] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
682 Muratori P, Lalanne C, Fabbri A, Cassani F, Lenzi M, Muratori L. Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype. Aliment Pharmacol Ther 2015;41:1281-7. [DOI: 10.1111/apt.13210] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
683 Kawaguchi T, Arinaga-Hino T, Shimizu M, Tanikawa K, Tokushige T, Hirai S, Nagamatsu H, Tateishi H, Takata A, Ide T, Torimura T. Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate. Intern Med 2019;58:2501-5. [PMID: 31118398 DOI: 10.2169/internalmedicine.2740-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
684 Sebode M, Schramm C, Lohse AW. [Inflammatory diseases with liver and joint involvement. A differential diagnostic challenge]. Internist (Berl) 2013;54:441-8. [PMID: 23455625 DOI: 10.1007/s00108-012-3191-6] [Reference Citation Analysis]
685 Taubert R, Jaeckel E. [Autoimmune hepatitis-standard and second-line therapy]. Internist (Berl) 2018;59:536-43. [PMID: 29725696 DOI: 10.1007/s00108-018-0434-1] [Reference Citation Analysis]
686 Adar T, Ilan Y, Elstein D, Zimran A. Liver involvement in Gaucher disease – Review and clinical approach. Blood Cells, Molecules, and Diseases 2018;68:66-73. [DOI: 10.1016/j.bcmd.2016.10.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
687 Sherigar JM, Yavgeniy A, Guss D, Ngo N, Mohanty S. Seronegative Autoimmune Hepatitis A Clinically Challenging Difficult Diagnosis. Case Rep Med 2017;2017:3516234. [PMID: 28761444 DOI: 10.1155/2017/3516234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
688 Altamirano J, Miquel R, Katoonizadeh A, Abraldes JG, Duarte-Rojo A, Louvet A, Augustin S, Mookerjee RP, Michelena J, Smyrk TC, Buob D, Leteurtre E, Rincón D, Ruiz P, García-Pagán JC, Guerrero-Marquez C, Jones PD, Barritt AS 4th, Arroyo V, Bruguera M, Bañares R, Ginès P, Caballería J, Roskams T, Nevens F, Jalan R, Mathurin P, Shah VH, Bataller R. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 2014;146:1231-9.e1-6. [PMID: 24440674 DOI: 10.1053/j.gastro.2014.01.018] [Cited by in Crossref: 221] [Cited by in F6Publishing: 205] [Article Influence: 27.6] [Reference Citation Analysis]
689 Imanieh M, Farzaneh NA, Dehghani SM, Shahrebabak MG, Hosseinabadi SH. Evaluation of Validity and Efficiency of Diagnostic Criteria in Autoimmune Hepatitis in Children. Turk J Gastroenterol 2021;32:526-31. [PMID: 34405819 DOI: 10.5152/tjg.2021.19305] [Reference Citation Analysis]
690 Lian JS, Liu W, Hao SR, Chen DY, Wang YY, Yang JL, Jia HY, Huang JR. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis. Hepatobiliary Pancreat Dis Int 2015;14:413-21. [PMID: 26256087 DOI: 10.1016/s1499-3872(15)60393-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
691 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol 2021. [PMID: 34580437 DOI: 10.1038/s41423-021-00768-8] [Reference Citation Analysis]
692 Beyazit Y, Efe C, Tanoglu A, Purnak T, Sayilir A, Taskıran I, Kekilli M, Turhan T, Ozaslan E, Wahlin S. Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis. Scand J Gastroenterol 2015;50:204-10. [PMID: 25495215 DOI: 10.3109/00365521.2014.974203] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
693 Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL. Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology 2013;58:1392-400. [PMID: 23686586 DOI: 10.1002/hep.26454] [Cited by in Crossref: 144] [Cited by in F6Publishing: 107] [Article Influence: 16.0] [Reference Citation Analysis]
694 Zhang HP, Liu YM, Li Z, Ma YX, Li LJ, Zhao DT, Lou JL, Gao ZH, Yan HP. Clinical characteristics and HLA genotypes in Chinese patients with anti-SLA/LP-positive autoimmune hepatitis. Ann Transl Med 2021;9:153. [PMID: 33569455 DOI: 10.21037/atm-20-8036] [Reference Citation Analysis]
695 Torisu Y, Nakano M, Takano K, Nakagawa R, Saeki C, Hokari A, Ishikawa T, Saruta M, Zeniya M. Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis. World J Hepatol 2017; 9(1): 57-63 [PMID: 28105259 DOI: 10.4254/wjh.v9.i1.57] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
696 Strassburg CP. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2010;24:667-82. [PMID: 20955969 DOI: 10.1016/j.bpg.2010.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
697 Zografos TA, Gatselis N, Zachou K, Liaskos C, Gabeta S, Koukoulis GK, Dalekos GN. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. World J Gastroenterol 2012; 18(34): 4721-4728 [PMID: 23002341 DOI: 10.3748/wjg.v18.i34.4721] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
698 Sebagh M, Castillo-Rama M, Azoulay D, Coilly A, Delvart V, Allard MA, Dos Santos A, Johanet C, Roque-Afonso AM, Saliba F. Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults. Transplantation. 2013;96:670-678. [PMID: 23982338 DOI: 10.1097/tp.0b013e31829eda7f] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
699 Han JY, Lee J, Kim JM, Joo K, Chon U, Lee JI, Jeong S, Lee DH, Kim YS, Min KS. A case report of alverine-citrate-induced acute hepatitis. Korean J Hepatol 2010;16:75. [DOI: 10.3350/kjhep.2010.16.1.75] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
700 Liberal R, Longhi MS, Grant CR, Mieli-Vergani G, Vergani D. Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol. 2012;10:346-353. [PMID: 22056300 DOI: 10.1016/j.cgh.2011.10.028] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
701 Ferri PM, Ferreira AR, Miranda DM, Simões e Silva AC. Diagnostic criteria for autoimmune hepatitis in children: A challenge for pediatric hepatologists. World J Gastroenterol 2012; 18(33): 4470-4473 [PMID: 22969217 DOI: 10.3748/wjg.v18.i33.4470] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
702 Luo L, Ma Q, Lin L, Wang H, Ye J, Zhong B, Huang M. Prevalence and Significance of Antinuclear Antibodies in Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Disease Markers 2022;2022:1-12. [DOI: 10.1155/2022/8446170] [Reference Citation Analysis]
703 Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, Tu C, Guo J, Zhang S, Wang J. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol. 2011;54:340-347. [PMID: 21056494 DOI: 10.1016/j.jhep.2010.06.032] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
704 Fernández MIC, Hernández DR, Cabrera Eugenio DE, Palanca W, Guridi ZD, González Fabián L. Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba. Curr Ther Res Clin Exp 2017;85:8-14. [PMID: 29158853 DOI: 10.1016/j.curtheres.2017.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
705 Abe K, Takahashi A, Imaizumi H, Hayashi M, Okai K, Kanno Y, Watanabe H, Ohira H. Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis. Springerplus. 2016;5:777. [PMID: 27386263 DOI: 10.1186/s40064-016-2512-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
706 Teles C, Santos R, Silva CD, Vaio T. Postinfantile giant cell hepatitis in the setting of autoimmune hepatitis: exclusively a histological pattern or a prognosis predictor? BMJ Case Rep 2021;14:e243660. [PMID: 34290027 DOI: 10.1136/bcr-2021-243660] [Reference Citation Analysis]
707 González IA, Hartley CP, Nalbantoglu I. Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft. Am J Clin Pathol 2021;155:435-45. [PMID: 33252121 DOI: 10.1093/ajcp/aqaa147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
708 Schultheiß C, Steinmann S, Lohse AW, Binder M. B cells in autoimmune hepatitis: bystanders or central players? Semin Immunopathol 2022. [PMID: 35488094 DOI: 10.1007/s00281-022-00937-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
709 Dauvergne M, Moktefi A, Rabant M, Vigneau C, Kofman T, Burtey S, Corpechot C, Stehlé T, Desvaux D, Rioux-Leclercq N, Rouvier P, Knebelmann B, Boffa JJ, Frouget T, Daugas E, Jablonski M, Dahan K, Brocheriou I, Remy P, Grimbert P, Lang P, Chazouilleres O, Sahali D, Audard V. Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases. Medicine (Baltimore) 2015;94:e1243. [PMID: 26222864 DOI: 10.1097/MD.0000000000001243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [